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ABSTRACT 

The emergence and spread of chloroquine-resistant Plasmodium Jalciparum strains 
has severely compromised the effectiveness of this drug. The mechanism of 
chloroquine resistance has yet to be elucidated. This thesis describes a method for 
the purification of Plasmodium Jalciparum plasma membranes. Membranes were 
isolated in an high enough yield to allow an investigation of the chloroquine 
accumulation properties and a characterisation of the ATPase activity displayed by 
these purified membranes isolated from chloroquine-sensitive and -resistant 
parasites. Marker enzyme assays, transmission electron microscopy and gel 
electrophoresis demonstrated the purity of preparations from parasite cytosol and 
erythrocyte contaminants. Chloroquine accumulation capabilities of the plasma 
membranes isolated from Plasmodium Jalciparum exhibiting various degree of 
chloroquine sensitivity was evaluated. Parasite plasma membranes isolated from two 
chloroquine-sensitive strains accumulated significantly more chloroquine than those 
isolated from two of the three chloroquine-resistant strains tested. However, since 
erythrocytes infected with CQS parasites accumulate chloroquine at a higher level 
than their resistant counterparts, it is difficult to link these results to a possible role 
of the parasite plasma membrane in determining the global level of chloroquine 
accumulation in the parasite. Furthermore, chloroquine accumulation in P. 
Jalciparum plasma membrane was shown to be ATP-independent. Subcellular 
localisation of Pghl indicated that this protein is present in Plasmodium Ja/ciparum 
plasma membrane but no link between the overexpression of Pghl and chloroquine 
sensitivity of the Plasmodium Jalciparum strains tested could be found. In addition, 
polyclonal antibodies directed at Pgh 1 were unable to inhibit chloroquine 
accumulation in purified plasma membranes, suggesting that Pghl is not involved as 
a chloroquine transporter in the plasma membrane of Plasmodium Jalciparum. 
Optimal Plasmodium Jalciparum plasma membrane ATPase activity was achieved 
with 2mM ATP and 2mM Mg2+. The effect of V-type and P-type ATPase inhibitors 
on the ATPase activity of parasite plasma membrane indicated the presence of a 
vacuolar proton pump in the plasma membrane of P. Jalciparum. This thesis also 
showed that verapamil and other agents known to reverse chloroquine resistance by 
increasing chloroquine accumulation in parasitised erythrocytes did not affect either 
chloroquine accumulation or the ATPase activity of isolated membranes indicating 
that resistance reversal do not occur at the plasma membrane level. 
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Chapter 1: Introduction 
CHAPTER 1 

INTRODUCTION 

1.1 Introduction 
Malaria remains one of the most serious infectious disease in tropical regions of the 
world, resulting in more than 400 million new cases every year mostly of young 
children and up to 1.5 to 2.7 million deaths (World Health Organisation, 1997). 
Human malaria is caused by four species of the Plasmodium parasite, namely P. 
jalciparum, P. vivax, P. ovale, and P. malaria. Of these species, the most abundant 
and fatal is P. jalciparum. Despite major control campaigns, the situation is 
deteriorating in many areas. Drug resistance, especially multi drug resistance, and 
difficulties in eradicating the mosquito vector have been the basis of malaria 
resurgence over the past 20 years. In addition, massive problems with logistic, 
planning, allocation of resources, and a lack of operational research have contributed 
greatly to the failure ofmalaria eradication 
An individual progressing episodically from shaking chills through intense fevers to 
drenching sweats is a classic description of the clinical manifestation ofmalaria. Other 
common symptoms includes headaches, jaundice, vomiting and diarrhea. Cerebral 
malaria caused by Plasmodium jalciparutn is responsible for the majority of deaths. 
Renal failure, hypoglycemia, severe anemia and pulmonary edema may also 
contribute to morbidity due to malaria. The severity of malaria illness depends largely 
on the immunological status of the infected individual. Partial immunity develops 
over time through repeated infections. Many infected people in areas where malaria is 
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Chapter 1: Introduction 
endemic are asymptomatic and therefore contribute greatly to the spread of the 
disease. 
1.2. Life cycle of the malaria parasite 
The parasite requires two hosts, a female Anopheles mosquito and a human. The life 
cycle of Plasmodium is a complex process consisting of an exogenous sexual phase 
(sporogony) in the mosquito and an endogenous asexual phase (schizogony) in 
human. The latter phase is itself divided in two developmental cycles, namely 
exoerythrocytic and erythrocytic stage. 
Plasmodium is transmitted to a human being by the bite of an infected female 
mosquito of the malaria-transmitting Anopheles species. The mosquito injects a small 
amount of saliva containing anticoagulants as well as parasite sporozoites. These 
sporozoites disappear rapidly from the circulation and enter the hepatic cells where 
they multiply. The merozoites released into the blood stream by rupture of the 
hepatocytes initiate the erythrocytic stage (Figure 1). During a 48-hr (or 72-hr for 
Plasmodium malariae) intraerythrocytic stage, the merozoite develops successively 
into a ring stage, a trophozoit , and finally a schizont, which divides into 16-24 
merozoites. After several successive erythrocytic cycles, some trophozoites become 
differentiated into sexual forms, namely gametocytes. The male and female 
gametocytes are the forms which are infective to the vector in which they fuse to 
form a zygote and initiate sporogony. The zygote matures into an ookinete, which 
penetrates the stomach wall of mosquito. The resulting oocyst asexually multiplies to 
form sporozoites, which migrate to the mosquito salivary glands. 
It is the intra-erythrocytic stages of the malaria parasite that produce the disease 
pathology. Most death occurs due to a complication of infections with P. Jalciparum, 
whereby erythrocytes infected with mature-stage parasites adhere to the vascular 
endothelium of post-capillary venules, particularly in the brain (For a review, see 
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Grau and De Kossodo, 1994). Whilst the blood forms of the parasites cause most of 
the pathology of the disease, they are also the stages that are most susceptible to 
attack by antimalarial drugs. 
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Figure 1: The intraerythrocytic cycle of the malaria parasite 
1.3. Prevention and control 
Attempts to eradicate mosquitoes have relied on environmental sanitation and use of 
insecticides. Larva stages of the mosquito are controlled by either eliminating 
potential breeding sites or by employing chemical and biological methods while the 
arsenal against the adult mosquitoes includes chlorinated hydrocarbons, 
organophosphate compounds, carbamates and pyrethroids. Although the extensive 
eradication programs of the 1950s, based on the insecticide control generated 
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impressive results in North America and Europe, by the mid-1960s, it became clear 
that eradication was not technically or economically feasible in many areas (World 
Health Organisation Expert Committee on Malaria, 1967). Due to selection pressure, 
mosquitoes have developed resistance to some pesticides, particularly to dichloro­
diphenyl-trichloroethane (DDT), the most widely used pesticide in public health. In 
1980, a total of 51 species of Anopheles showed resistance to pesticides, 34 ofwhich 
were resistant to DDT and 30 of those were cross-resistant to other pesticides 
(Bruce-Chwatt, 1985). More recently, pyrethroid-resistant Anopheles gambia have 
been reported in Western Africa (Chandre et al., 1999). Another approach consists of 
avoiding contact with the mosquitoes. Protective clothing, insect repellents, mosquito 
coils, and bednets have been shown to be effective in reducing the incidence and 
prevalence of malaria in some areas. 
Vaccination would be a major advance in malaria control. The feasibility of a malaria 
vaccine is supported by two observations: first, volunteers immunised with irradiated 
sporozoites were protected against challenge with heterologous Plasmodium 
Jalciparum sporozoites (Clyde, 1975) and, second, 3-10 years of continuous 
exposure to naturally transmitted Plasmodium Jalciparum prevents severe disease 
and death as long as exposure is maintained (Mc Gregor et al., 1956). Vaccination 
with SPf66, a synthetic peptide polymer containing sequences from several malarial 
proteins, had been promising showing 38.8% efficacy in human trials conducted in 
South America (Valero et al., 1993) and evidence of borderline efficacy in Tanzania 
(Alonso et al., 1996). Unfortunately, field trials in The Gambia (D'Alessandro et al., 
1995) and in Thailand (Nosten et al., 1996) were not as successful and failed to show 
any protection against Plasmodium Jalciparum in infants. Another promising vaccine, 
the pre-erythrocytic RTS,S vaccine based on the circumsporozoite surface protein 
(CSP) of Plasmodium Jalciparum genetically linked to the hepatitis surface (HBs) 
antigen provided protection against homologous challenge in 6 out of 7 malaria-naive 
volunteers (Stoute et al., 1997). However, an ideal vaccine shoulc.l induce immune 
responses against each stage of the Plasmodium spp life cycle. Antigens from 
sporozoites (eSp, SSP2ITRAP), the liver stage, merozoites (MSP-1, AMA-1), 
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trophozoites, gametocytes (pfs48/45), toxic products released from infected 
erythrocytes and the infected erythrocytes are all under investigation for a vaccine 
development (Doolan et al., 1997). Still other approaches to vaccine development 
such as the multiple gene or multiple antigen are expected. 
As there is not yet a useful vaccine against this disease, the major forms of treatment 
and control still rely on the use of chemotherapeutic agents. Quinine extracted from 
the Cinchona tree was the first treatment for malaria to reach the Western world. 
Quinine has its origin in Peru, where Indians chewed the bark of the Cinchona tree to 
combat bad fever. In 1820, a method of purifying quinine from these trees was 
developed by Pelletier and Caventou in Paris (Russell, 1955). Salts of the isolated 
alkaloid, quinine soon became available commercially for clinical use and this 
remained the only source of this drug until it was synthesised in 1944. Quinine is now 
considered too toxic for prophylaxis or routine treatment of malaria, but it is still 
used as an intravenous injection to treat severe malaria. In 1946, as a result of a 
large-scale s~arch for less toxic analogues of quinine, the 4-aminoquinoline, 
chloroquine was produced (Loeb et al., 1946). Chloroquine has been used 
extensively ever since, because of its efficiency and safety, particularly in pregnant 
women, and its low cost. 
Due to increases in the incidence of infection of U.S. army troops in Vietnam with 
chloroquine-resistant Plasmodium Jalciparum, a large drug screening programme 
was initiated by the Walter Reed Army Institute of research, that lead to the 
development of mefloquine and halofantrine (Ohnmacht et al., 1971; Colwell et al., 
1972; Schmidt et ai., 1978a and 1978b). Mefloquine is most effective against 
multi drug resistant strains of Plasmodium Jalciparum although reports indicate that 
mefloquine resistance have emerged (Nosten et al., 1991). Other antimalarials that 
have been developed include the quinine-like compounds such as amodiaquine and 
proguanil and the antifolate antagonists (pyrimethamine and sulfadoxine). More 
recently, a new class of compounds, the sesquiterpene endoperoxide has emerged 
with the isolation of artemisinin in 1972 from a traditional Chinese medicinal herb 
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Qinghao (Artemisia annua) (Klayman, 1985). Artemisinin and its derivatives have 
been shown to be particularly effective against most multi-resistant parasites. 
Furthermore, these drugs have been widely used in China where 1 million patients 
have been treated with no significant toxicity reported up to now (Hien and White, 
1993). However, the generation of artemisinin-resistant mutants of Plasmodium 
falciparum after mutagenic treatment with N-methyl-N' -nitronitrosoguanosine has 
demonstrated the possibility of the development of resistance to this new antimalarial 
(Inselburg, 1985). Resistance of Plasmodium falciparum to all the major drugs used 
for the treatment of malaria has emphasised the need to develop novel antimalarial or 
to find a mechanism that circumvents the phenomena of drug-resistance. ' 
1.4. Chloroquine 
Chloroquine is the most common, well-tolerated and cost-effective drug for 
prophylaxis and therapy of malaria. It was widely used before the first resistant 
parasites were detected in 1959 in South America and a year later in South Asia. 
Since this time, resistance has spread rapidly and it is now present in all regions 
where malaria is endemic. Over the last 30 years, chloroquine resistance has become 
an increasingly serious problem. Chloroquine has been mixed with food, in the 1950s 
in order to control malaria at the population level. This has probably contributed to 
the development of chloroquine resistance by exposing parasites to sublethal 
concentrations. It is still not fully understood how P. falciparum becomes resistant to 
chloroquine. 
1.4.1. Mechanism of chloroquine action 
Early studies suggested that interaction of chloroquine with plasmodial DNA might 
be responsible for the antimalarial activity of the drug by inhibiting DNA replication 
and RNA synthesis. However, the concentrations of chloroquine required to inhibit 
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the growth of parasite were three orders of magnitude lower that those that had been 
reported to inhibit DNA synthesis (Parker and Irvin, 1952). Furthermore, chloroquine 
interacts more strongly with CG-rich DNA (Allison et al., 1965) while the plasmodial 
DNA is strikingly AT-rich. Thus, this theory could not explain the preferential 
inhibition ofmalaria parasites as compared to the host cells. 
Early clinical investigations of the antimalarial activities of chloroquine noted that 
drug action was limited to those stages of the parasite life cycle, which were actively 
degrading hemoglobin. It has been shown that rings, trophozoites and young 
gametocytes of P. Jalciparum were morphologically degenerated by chloroquine 
treatment while exoerythrocytic stages were unaffected (Fairley, 1947). After 
treatment with chloroquine, the first changes that are seen in ultrastructural 
examination are the swelling of the parasite food vacuoles and accumulation of 
undigested hemoglobin in endocytic vesicles (Macomber et ai., 1967; Aikawa, 1972) 
supporting the idea that the food vacuole is the site ofchloroquine action. It has been 
assumed, therefore, that chloroquine interferes with the metabolic processes involved 
in the uptake or digestion ofhemoglobin. 
Chloroquine accumulates in the acid food vacuoles of Plasmodium Jalciparum 
partially as a result of its properties as a weak base. Chloroquine is a diprotic weak 
base (PKal=8.1, pKa2=1O.2). In its uncharged form, it can diffuse freely through 
membrane into the cell. In acidic compartments, it will be doubly protonated and 
membrane impermeable. Therefore, the extent of chloroquine accumulation depends 
on the difference in pH between the parasite food vacuole and the extracellular 
environment (Homewood et ai., 1972). Krogstad et al. (1985) measured the pH of 
the food vacuole (pH 5.2-5.4) by spectrofiuorimetry. They showed that the vacuoles 
could be stimulated to acidify their interior by the addition of MgATP and have their 
internal pJI increased by the addition of weak bases. They also demonstrated that 
chloroquine as well as ~CI inhibited parasite growth at concentration virtually 
identical to those that increased parasite vacuole pH. The alkalinisation of the food 
vacuole as a result of chloroquine accumulation would inhibit the hydrolytic enzymes 
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responsible for hemoglobin degradation which function optimally at an acidic pH 
(Goldberg at al., 1990). Chloroquine has also been shown to directly inhibit the 
activity of partially purified hemoglobin-degrading proteases (Vander et Jagt, 1986) 
and the protein degradation in trophozoite-infected erythrocytes (Zarchin et al., 
1986). This lead to the hypothesis that inhibition of lysosomal function might lead to 
an inhibition of hemoglobin digestion and starvation of the parasite (Homewood et 
aI., 1972). However, none of these effects can explain the selective activity of 
chloroquine against the parasite. While the inhibition of hemoglobin digestion by 
protease inhibitors is reversible upon removal of the inhibitor (Rosenthal et al., 
1988), the inhibition of parasite growth by chloroquine is irreversible (Ginsburg and 
Krugliak, 1992). Moreover, mathematical modelling by Yahon et al. (1985) 
suggested that at therapeutic levels, chloroquine accumulation caused minor changes 
in the food vacuole pH. However, the idea that chloroquine accumulation leads to 
alkalinisation was supported by Krogstad and Schlesinger (1987b ) as it was 
demonstrated that biologically active concentrations of chloroquine increase the pH 
of the parasite's food vacuole. 
One of the most likely hypotheses to explain the action of chloroquine is the 
decoupling of ferriprotoporphyrine IX sequestration into hemozoin. The parasite 
degrades the hemoglobin in the food vacuole, and uses the amino acids as a major 
nutrient source. When ferrous heme is released from globin it oxidizes into the 
ferriprotoporphyrine IX which is toxic to the parasite. This ferric form can damage 
membranes and inhibit various enzymes including proteases. Rather than degrading or 
excreting the heme, the parasite has evolved a novel pathway for its detoxification by 
incorporating it into an insoluble crystalline form called haemozoin or malaria 
pigment. The haemozoin is a non-toxic polymer of heme units linked by the central 
ferric ion of one unit to the carboxylic side group of the next heme group (Slater et 
al., 1991). 
Following early observations that free FPIX was able to form complexes with 
chloroquine (Cohen et al., 1964; Macomber et al., 1967) it was hypothesized that 
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chloroquine exerted its effect by fonning toxic complexes with free FPIX released in 
situ (Chou and Fitch, 1980a). More recent work has shown that chloroquine is able 
to inhibit the polymerisation of hematin, suggesting a mechanism by which free FPIX 
or FPIX-chloroquine complexes may concentrate in the food vacuole causing the 
parasite death (Slater and Cerami, 1992). It was initially believed that this reaction 
was catalysed by a haem polymerase and that chloroquine inhibited this polymerase 
activity. The fact that this polymerase ~ctivity could survive extensive boiling and 
protease treatments argued against a proteinaceous catalyst (Dom et aI., 1995). 
Instead, the heme polymerising activity of the parasite extract has been shown to be 
due to the presence of preformed heme polymers. These polymers of heme are 
thought to act as nucleation centres, allowing the efficient addition of further heme 
monomers. In addition, it was shown that spontaneous formati n of ~-haematin 
polymers can be induced in vitro and that this process is directly inhibited by 
chloroquine (Egan et al., 1994). These data suggest that chloroquine inhibits 
hemozoin elongation, probably by formation of a chloroquine-heme complex. There 
is also evidence indicating that chloroquine depolymerise prefotmed complexes 
(pandey and Tekwani, 1997). Further evidence that FPIX is the receptor for 
chloroquine came from studies using the plasmepsin I inhibitor, Ro 40-4388. This 
inhibitor was shown to be antagoni tic to the antimalarial action of chloroquine on 
cultured parasites (Moon et al., 1997; Mungthin et al., 1998; Bray et al., 1999). 
Plasmepsin I is an aspartic proteinase involved in hemoglobin degradation (Gluzmann 
et al., 1994); its inhibition prevents the FPIX release from hemoglobin, thereby 
removing the chloroquine target. Inhibition ofparasite enzymes (Ginsburg and Geary, 
1987; Vander Jagt et al., 1987) and disruption of membranes (Otjih, et al., 1981) by 
free heme or chloroquine-heme complexes could account for the toxic effect 
mediated by chloroquine. 
Recently, the inhibition ofglutathione-dependant degradation ofheme by chloroquine 
as been proposed as an explanation for its antimalarial action (Atamna and Ginsburg, 
1995). Surprisingly, only 30% of the heme appears to be sequestrated into haemozoin 
in Plasmodium Jalciparum (Ginsburg et al., 1998; Loria et al., 1999). Atamna and 
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Ginsburg (1995) argued that the excess heme translocates across the food vacuole 
membrane to reach the parasite cytosol where it is degraded by glutathione. Recently, 
chloroquine was demonstrated to inhibit the gluthatione-dependent degradation of 
heme. Moreover, it has been shown that treatment of Plasmodium falciparum­
infected erythrocytes with chloroquine results in a dose- and time-dependant 
accumulation of heme in the membrane fraction of these cells in correlation with the 
cytotoxic effect of the drug (Ginsburg et al., 1998; Famin et ai., 1999). Thus the 
inhibition of glutathione-dependant degradation of heme would result in increased 
levels of free heme. 
Another explanation for chloroquine action could be the inhibition of the peroxidase 
degradation of haem. The parasite has to face two major toxic waste problems: the 
release of heme and the production of H202. Upon degradation of hemoglobin, the 
heme is oxidised from the Fe(II) state to the Fe(III) state which results in the 
production ofH20 2(Atamna and Ginsburg, 1993). In the food vacuole, host-derived 
catalase and peroxidase might contribute to H202 breakdown although parasite 
proteases will rapidly destroy the host enzymes. It has been shown that heme can 
react with H20 2displaying both catalase and peroxidase activities (Green et al., 1996) 
and that chloroquine is an efficient inhibitor of the catalase activity of heme (Ribeiro 
et al., 1997; Loria et ai., 1999). Moreover, under conditions designed to resemble 
those found in the food vacuole, i.e., at pH 5.2 in the presence of protein, it was 
found that the catalytic activity of haem could contribute significantly to the 
degradation of haem and to the breakdown of reactive oxygen species (Loria et al., 
1999). Therefore, a possible route to degradation of haem is by reacting with H202. 
Consequently, it has been proposed that chloroquine exerts its antimalarial activity by 
causing a build-up of H202 which may cause peroxidative damages to proteins and 
lipids. 
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1.4.2. Mechanism of chloroquine resistance 
The biochemical basis of resistance is not completely understood. However, 
chloroquine is concentrated in the acidic vacuole of the parasite and it is clear that 
resistant parasites accumulate less chloroquine than sensitive isolates. The mechanism 
by which chloroquine resistant parasites accumulate less chloroquine is highly 
controversial but four basic possibilities exist. (1) A rapid effiux of chloroquine from 
chloroquine resistant parasites, (2) an insufficient chloroquine uptake mechanism in 
chloroquine resistant parasites due to a defective food vacuole acidification, an 
alteration in membrane permeability or in the specificity of an permease or other 
transporters or by sequestration of chloroquine in another compartment of the .cell, 
(3) an alteration in the drug target site, (4) by metabolism of chloroquine into an 
inactive form. 
1.4.2.1. Chloroquine metabolism by the parasite 
Cytochrome P-450-dependant activities (Salganik et al., 1987) have been 
demonstrated and an association between chloroquine susceptibility and cytochrome 
P-450 drug-metabolising enzyme activity has been found in both Plasmodium 
berghei and Plasmodium jalciparum (Ndifof et al., 1990). Cimetidime and other 
, 
agents known to inhibit cytochrome P-450 enzymes were able to enhance parasite 
susceptibility in Plasmodium jalciparum in vitro and Plasmodium berghei in vivo 
(Ndifor et ai., 1993). However, thin-layer chromatography studies showed that 3H_ 
chloroquine accumulated in resistant Plasmodium jalciparum parasites was 
indistinguishable from the parent compound (Gluzmann et al., 1987). 
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1.4.2.2. Increased chloroquine efflux 
It was originally proposed that chloroquine-resistance was associated with an efflux 
mechanism. This hypothesis relied on the existence of a verapamil-sensitive drug 
exporter which is thought to be responsible for an apparent increase in the rate of 
efflux: ofchloroquine from chloroquine resistant parasites compared with chloroquine 
sensitive parasites, resulting in a greater reduction of drug accumulation within the 
infected erythrocyte in chloroquine-resistant parasites than in chloroquine-sensitive 
parasites (Krogstad et al., 1987a). It was found that the initial rate of chloroquine 
uptake was identical in sensitive and resistant strains. Furthermore the initial rate of 
efflux was demonstrated to be more rapid from the resistant parasites than the 
sensitive even when equivalent amounts of chloroquine were preaccumulated by the 
sensitive and resistant parasites. This accelerated efflux of chloroquine is energy­
dependent as it is inhibited by the removal of glucose or the addition of the ATPase 
inhibitor vanadate (Krogstad et al., 1992). However, the biochemical data indicating 
an increased level of chloroquine efflux in chloroquine-resistant parasites have since 
been questioned (Ginsburg and Kruigliak, 1992) and subsequent studies have 
indicated that efflux: rates of chloroquine-resistant and -sensitive strains are similar 
(Bray et al., 1992a). 
It has been suggested that the mechanism of chloroquine resistance has similarities 
with the multidrug resistance phenotype of mammalian tumor cells, as verapamil, an 
agent which reverses multi drug resistance of tumor cells is also able to modulate 
chloroquine resistance (Martin et al., 1987). The mechanism of resistance in tumor 
cells can be defined as increased drug efflux that is mediated by increased expression 
of the P-glycoprotein (Cornwell et aI., 1986). This P-glycoprotein is an ATP­
dependent pump encoded by the mdr gene which is amplified in tumor lines resistant 
to multiple drugs. 
Plasmodium jalciparum has been shown to possess at least two mdr-like genes 
(pjmdrl and pjmdr2), one of which has been suggested to confer the chloroquine 
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resistant phenotype. Pfmdrl has been sequenced (Foote et al., 1989) and has been 
shown to encode a 160 kDa P-glycoprotein homologue (Pghl). Mammalian mdr 
genes typically share 50% homology with pfmdrl (Foote et aI., 1989). The 
Plasmodium Jalciparum P-glycoprotein is of interest because its putative transport 
function is unknown and because it has been linked to the chloroquine resistance 
phenotype. Cowman et al. (1991) showed that Pghl is localised primarily to the 
membrane of the digestive vacuole ofPlasmodium Jalciparum trophozoites and that 
a small fraction appears to be localised to the parasite membrane. However, 
photoaffinity studies using a photoreactive analogue of chloroquine failed to 
demonstrate an interaction of chloroquine with Pgh1 in P. Jalciparum (Foley et al., 
1994). 
Pgh1 belongs to the superfamily of ATP- binding cassette transporters (ABC). 
Members of this group include the cystic fibrosis transmembrane conductance 
regulator (CFTR), the mating pheromone transporter in Saccharomyces cerevisiae 
(ste6), the mammalian multidrug r((sistance-associated protein (MRP), hlyb and 
others transporters found in bacteria (Higgins, 1992). The typical ABC transporter, 
including Pghl, is formed by two highly homologous halves (62% homology) 
connected by a hydrophilic linker region. Each half contains six predicted 
transmembrane domains, glycosylation consensus sequences, and one consensus site 
for ATP-binding. The latter site contains two short motifs, the Walker motif 
associated with ATP-binding properties (Walker et al., 1982). 
It has been demonstrated that transport is dependent on ATP-binding and hydrolysis 
(Cornwell et aI., 1987b). It has also been shown that chemosensitisers reverse MDR 
by increasing accumulation of drug within cells, bind specifically to membrane 
vesicles from MDR cells and inhibit vinblastine analogue photo affinity labelling ofthe 
P-170 (Cornwell, 1987a). Photoaffinity data reveals that some drugs bind to the 
MDR protein (Cornwell, 1986), although this is indirect evidence for active transport 
since many transporters bind compounds specifically but do not transport them 
(amiloride and Na+JW exchanger, stilbene and CrIHC03- exchanger, etc.). 
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Measurement of intracellular pH (pHi) for MDR cells reveals that it is closely 
correlated with the relative steady-state of efflux, suggesting that the relevant 
function of MDR-protein expression in these cells may be to raise intracellular pH 
directly or indirectly such that less drug is sequestered in a charge-dependent manner 
(Roepe, 1992). This author also found that verapamil affects pHi significantly in the 
resistant cells and suggested that the MDR protein modulates intracellular pH and 
indirectly promotes the efflux of chemotherapeutic without performing active drug 
transport. It has been reported that Pgp can function as an ATP-dependent, cell 
volume-regulated chloride channel (Gill et al., 1992; Valverde et al., 1992). 
However, it is possible that Pgp rather act as a chloride channel regulator (hardy et 
al., 1995; Bond et at., 1998). 
Pgh1 is expected to share at least some of these features with other P-glycoproteins, 
although presently only ATP-binding has been demonstrated for Pgh1 (Karcz and 
Cowman, 1991). Initially, Pgh1 present on the food vacuole membrane was thought 
to expel drugs from this organelle and therefore overexpression of Pgh 1 was 
expected to increase the rate of removal ofchloroquine from Plasmodium falciparnm 
thereby rendering the parasite chloroquine resistant. It was also proposed that amino­
acid substitution favouring expulsion might occur in the protein. However, the 
protein is orientated with its nucleotide-binding domain exposed to the parasite 
cytoplasm (Karz et al., 1993b), which suggests pumping of substrate into the food 
vacuole rather than out. Nevertheless, mutation in pfmdr1 may have changed the 
substrate specificity of the wild-type (CQS) protein in such a way that chloroquine 
became a poor substrate. The same mutation associated with chloroquine resistance 
may also have affected translocation of essential endogenous substrates ofPghl into 
or out of the digestive vacuole. It has been difficult to correlate any overexpression 
or mutation in this protein with chloroquine resistance. Foote et al. (1989) found that 
the mdr gene was amplified in some resistant isolates but not in any seI).sitive ones, 
while Wilson et al. (1989) correlated amplification of the same gene with increased 
mefioquine, but not chloroquine resistance. To determine if pfmdrl was linked to 
chloroquine resistance, Wellems et al. (1990) performed a genetic cross between 
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chloroquine-resistant and chloroquine-sensitive clones of Plasmodium Jalciparum. 
Their result showed that the rapid efflux is controlled by a single gene or a closely 
related group of genes but there was no linkage between the rapid efflux, 
chloroquine-resistant phenotype and pfmdr1. Analysing the complete sequence of 
two chloroquine-resistant (CQR) and 5 chloroquine-sensitive (CQS), Foote et al. 
(1990) were able to predict the CQS/CQR status of a further 34 out of 36 isolates. 
They predicted that both a pfmdr1 allele competent for chloroquine-resistance and a 
mutation in a second unknown gene is required for chloroquine-resistance. However, 
further studies showed that the level of chloroquine resistance in a number of field 
isolates of a Plasmodium Jalciparum did not correlate with the level of Pghl 
expression (Cowman et aI., 1994) and there was no correlation between particular 
alleles of pfmdr1 and chloroquine resistance (Wilson et al., 1993). It is therefore 
unlikely that an amplification of the pfmdr1 is responsible for chloroquine resistance. 
Using an heterologous expression system for the pfmdr1 gene to express Pgh1 in 
CHO cells, Van Es et al. (1994a) found that wild-type Pgh1 can mediate chloroquine 
accumulation whereas CQR-associated mutated form of the protein cannot. This 
finding demonstrates that there is more than one CQR mechanism which probably 
involves different sets of genes, depending on the Plasmodium Jalciparum isolate 
analysed. 
It was first demonstrated that CQR strains of Plasmodium Jalciparum could be 
sensitised by verapamil (Martin et al., 1987). Later studies revealed that CQR in this 
parasite could also be reversed by tricyclic anti-depressants including desipramine 
(Basco et al., 1990) and tricyclic anti-histamines such as cyproheptadin. The ability 
of verapamil to increase steady-state chloroquine accumulation was found to be 
totally insufficient to explain the increase in chloroquine activity by the drug. In 
contrast, when chloroquine accumulation was increased by raising the medium pH, 
the corresponding shift in sensitivity to chloroquine could be accurately predicted 
(Bray et al., 1994). It is possible that verapamil could inhibit the efflux ofchloroquine 
from a low capacity, high affinity site inside the parasite. These data have suggested 
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that at least in highly chloroquine-resistant parasites, two phenotypically distinct 
mechanisms for chloroquine-resistance exist, one that is verapamil reversible, and one 
that is not. 
1.4.2.3. Reduced uptake 
. Many studies have demonstrated that chloroquine resistance is associated with a 
reduced initial rate of drug uptake (Ginsburg et al., 1991; Bray et al., 1994; Martiney 
et al., 1995). Early studies have demonstrated that chloroquine uptake into 
Plasmodium Jalciparum consisted of a component which is saturable at nanomolar 
concentrations and a component which is non-saturable in the submicromolar range 
(Fitch, 1970). There are number ofhypotheses accounting for a reduced uptake. 
1.4.2.3.1. Weakened proton pump 
As chloroquine accumulates in the food vacuole due to its weak base properties, the 
reduced accumulation of chloroquine in resistant parasites could result from a 
modified pH (Geary et al., 1990). Kinetic modeling of chloroquine uptake by 
sensitive and resistant Plasmodium Jalciparum )Vas shown to be consistant with the 
decrease activity of a vacuolar proton pump (Ginsburg and Stein, 1991). Bray et al. 
(1992b) hypothesize that the intravacuolar pH of resistant strains is higher than for 
sensitive strains as a consequence of a weakened pump in the vacuole of resistant 
strains. This hypothesis was supported by the fact that Bafilomycin Al significantly 
reduces uptake of eH]-chloroquine into both chloroquine resistant and chloroquine 
sensitive strains of Plasmodium Jalciparum. Furthermore, chloroquine resistant 
strains were found more sensitive to Bafilomycin Al than chloroquine sensitive 
strains. Although, the genes encoding the A subunit (V AP-A) and the B subunit 
(V AP-B) of the plasmodial vacuolar proton pump have been cloned, no mutations 
16 

Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 1: Introduction 
have been found that can account for chloroquine resistance (Karcz et al., 1993a; 
Karcz et al., 1994). 
1.4.2.3.2. Regulation of a chloride-channel 
Ferrari et al. (1991) claimed that chloroquine resistance is not the consequence of a 
specialised drug-exporter in erythrocytes infected with chloroquine resistant 
parasites, which is absent or deficient in chloroquine sensitive strains, but rather the 
consequence of the presence of a drug importer in erythrocytes infected with 
chloroquine sensitive parasites, which is deficient in chloroquine resistant parasites. 
Van Es et al. (1994b) investigated the role ofPghl in chloroquine transport using a 
heterologous expression system. Transfection of Chinese hamster ovary cells with 
pfmdrJ led to expression of Pghl in the lysosomes, which was associated with a 
decrease in lysosomal pH. Moreover, Chinese hamster ovary cells expressing the 
Pghl protein demonstrated an increased verapamil-sensitive susceptibility to 
chloroquine while those expressing a mutated Pghl did not (Van Es et al.,1994a). 
This result suggests that Pghl acts as a chloride channel, enhancing chloroquine 
accumulation by modulating the P. Jalciparum vacuolar pH, as has been 
demonstrated for some other members of the P-glycoprotein family (Valverde et al., 
1992). 
When Martiney et al. (1995) forced CQR trophozoites to become phenotypically 
sensitive by weak base manipulation, they found that verapamil increased the 
susceptibility of the CQR but has no effect on the toxicity of chloroquine on the 
CQS. They concluded that verapamil specifically increases chloroquine accumulation 
in genetically resistant Plasmodium Jalciparum trophozoites independently of weak 
base processes and phenotypic susceptibility due to external pH manipulation. They 
raised the hypothesis that the mutation conferring CQR in Plasmodium Jalciparum 
up-regulates a chloride channel regulator protein, which alters ion conductances that 
17 
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indirectly control drug transit within the parasite's cytoplasm by setting the 
cytoplasmic pH and this chloride channel regulator is inhibited by verapamil during 
reversal of resistance. Thus, while genetic studies indicate that pfmdr1 mutations are 
not sufficient to confer chloroquine resistance, it is possible that they may be involved 
in modulating the level of drug resistance. 
1.4.2.3.3. Reduced affinity of a chloroquine importer 
Warhust (1988) has suggested that a drug carrier or permease exists within the 
membrape of the intraerythrocytic parasite that transports chloroquine from the host 
erythrocyte cytosol to the parasite cytosol, thus facilitating drug uptake into the 
parasite. Drug resistance could then arise from either a decrease in the number or 
efficiency of the permease units. 
More recent work has implicated a plasmodial Na+/:W exchanger (NHE) in the 
facilitated import of chloroquine (Sanchez et al., 1997). This group demonstrated 
that both CQR and CQS P. falciparum possess a chloroquine importer with a single 
binding site for chloroquine and linked altered saturation kinetics of initial 
chloroquine uptake to the chloroquine-resistant phenotype. All the progeny of a 
genetic cross between a CQS and strain and a CQR strain ofP. falciparum (We11ems 
et al., 1991) exhibit comparable kinetics of one or the other of the parental strains, 
indicating the influence of a single gene on this phenotype (Sanchez et al., 1997). 
Amiloride derivatives known as specific inhibitors of Na + IIr antiport, competitively 
inhibited the initial uptake of chloroquine into infected-erythrocytes leading to the 
suggestion that chloroquine is directly transported by the parasite plasma membrane 
NHE in place of sodium and in exchange of protons. Further studies indicated that 
the NHE of CQS parasites was stimulated by chloroquine suggesting that this drug is 
taken up by the NHE in the ensuing rapid burst of sodium proton exchange (Wunsch 
et al., 1998). Subsequently, it was proposed that the NHE of CQR parasites was 
unable to transport chloroquine, since it was constitutively activated and insensitive 
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to further stimulation by chloroquine. The reversal of chloroquine resistance by 
verapamil was proposed to occur via a calcium/calmodulin-dependent pathway, 
although no evidence was presented (Sanchez et al., 1997). 
Bray et al. (1999) have questioned the validity of this model since replacement of 
sodium in the incubation buffer by a non-transportable cation such as choline did not 
result in enhanced uptake by isolated CQS parasites, suggesting that any al?ility of 
chloroquine to stimulate the NHE of CQS parasites (Wunsch et aI., 1998) is 
unrelated to the mechanism of chloroquine uptake. In addition, stimulation of 
chloroquine uptake into CQR parasites was retained in sodium-free buffer. Therefore, 
these results are incompatible with the notion that verapamil modulates the NHE 
activity via a calciUm/calmodulin-dependent pathway (Sanchez et ai., 1997). 
Analysis of a genetic cross between a chloroquine-sensitive and chloroquine-resistant 
strain ofPlasmodium Jalciparum identified a single chloroquine-resistant locus within 
a 400kb segment of chromosome 7 (Well ems et al., 1990, 1991). Recently, this locus 
was mapped to a 36-kb region and a candidate gene, cg2, has been identified within 
this region (Su et ai., 1997). The cg2 protein encodes a 330-kDa protein, which has 
been shown by immunogold electron microscopy to be located at both the 
parasitophorous membrane, the space separating the parasite from the erythrocyte 
host, and the food vacuole. Ol1e particular set of polymorphism correlates with 
chloroquine resistance while numerous differences were observed in sensitive 
parasites. However, one clone from Sudan was found to have the polymorphism 
associated with the chloroquine resistant phenotype, but exhibited chloroquine 
sensitivity. The possibility that the cg2 protein is an integrated Na+jff" exchanger was 
raised, although, there is no evidence to support this hypothesis (Sanchez et al., 
1998). However, the function of cg2 has not been established and another promising 
candidate, pfcrt, is also being investigated for its role in the mechanism of 
chloroquine-resistance (Wellems, personal communication to our laboratory). 
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1.4.2.3.4. Reduced affinity of chloroquine-FPIX binding 
Chloroquine has been shown to form complexes with free hematin in vitro (Chou et 
al., 1980b) and it was originally suggested that saturable uptake into cells was due to 
the binding of chloroquine to hematin in the plasmodial food vacuoles. This 
hypothesis was refuted since the amount of FPIX present in the food vacuole was 
estimated to be insufficient to account for the total chloroquine uptake in the 
infected-erythrocytes (Ginsburg et al., 1987). However, it has been since 
demonstrated that a high proportion of total uptake is non-saturable and only the 
saturable component of drug uptake is relevant to antimalarial activity (Bray et al., 
1998). Recent evidence found that FPIX produced by the parasite is enough to fully 
account for the saturable accumulation of chloroquine. The number of chloroquine 
binding sites in the parasite is significantly reduced by the presence ofRo 40 -4388, a 
specific inhibitor of hemoglobin proteolysis, indicating that hematin binding is 
required for chloroquine concentration into the food vacuole. Bray et al. (1998) 
suggested that the specific accumulation and antimalarial activity of chloroquine are 
all determined by the saturable equilibrium binding of chloroquine to FPIX. Recently, 
it was found that chloroquine-resistant parasites have a reduced apparent affinity of 
chloroquine-FPIX binding that is reversible by verapamil, compared with 
chloroquine-sensitive parasites (Bray et al., 1999). Therefore, it has been postulated 
that the altered binding ofchloroquine to FPIX could be achieved by direct binding to 
FPIX or by altering vesicular pH or buffering capacities. 
1.5. Scope of the study 
Chloroquine has to cross several membranes, the erythrocyte plasma membrane, the 
parasitophorous membrane, the parasite plasma membrane and the membrane of the 
food vacuole before reaching the food vacuole cytosol where it accumulates. The 
contribution of these membranes to the process of chloroquine accumulation has not 
yet been clearly defined; neither has their possible role in resistance. Chloroquine 
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accumulation has been extensively studied in purified food vacuoles and it has been 
shown that chloroquine accumulates approximately 20-fold less in isolated food 
vacuoles than in the same number of infected-erythrocytes (Saliba et al., 1998), 
suggesting that (1) the food vacuole might not be the major site of accumulation or 
might require a cytosolic factor to allow chloroquine transport, (2) the isolated food 
vacuoles might be leaky, (3) the purified food vacuoles are not producing heme. 
However, another likely explanation could be that other membranes might have a role 
in concentrating chloroquine in the parasitised erythrocytes. Erythrocyte ghosts from 
infected erythrocytes as well as membrane vesicles from infected erythrocytes have 
been prepared (Herwaldt et aI., 1990). Unfortunately these membrane vesicles 
comprised several membranes present in the infected-erythrocytes, therefore 
impeding the elucidation of their participation in the mechanism of chloroquine 
accumulation. Purified preparation of parasite plasma membranes would represent a 
major experimental advance for approaching this problem. For this reason, a method 
was developed to prepare pure and intact parasite plasma membranes from 
Plasmodium falciparum infected-erythrocytes in order to study its possible 
involvement in the mechanism of chloroquine accumulation and resistance. 
This study aims to investigate whether parasite plasma membrane vesicles isolated 
from sensitive and resistant Plasmodium falciparum are capable of differential 
chloroquine accumulation and whether reversal of chloroquine resistance occurs at 
the parasite plasma membrane level. Optimal condition for assaying the ATPase 
activity of these membranes will be determined and P-type and V-type ATPase 
inhibitors will be used to investigate any correlation between the ATPase activities 
and the level of chloroquine accumulation in parasite plasma membranes isolated 
from sensitive and resistant strains of Plasmodium falciparum. Since Pghl has been 
reported to be expressed on the parasite plasma membrane, antibodies against Pghl 
will be used to identify and locate this protein in the parasitised erythrocytes and 
plasma membranes isolated from various strains of P. falcipanJm in order to 
determine whether its expression on the plasma membrane correlates with the 
chloroquine sensitivity of the strain. Moreover, the effect of these antibodies on 
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chloroquine accumulation by purified parasite plasma membranes will be assessed in 
order to determine the role of Pghl in chloroquine accumulation at the parllsite 
plasma membrane leveL 
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CHAPTER 2 
Isolation of trophozoites and parasite plasma membranes 
2.1 Introduction 
Plasmodium Jalciparum can be obtained by continuous culture of parasitised human 
erythrocytes (Trager and Jensen, 1976). Although extracellular, axenic development 
of the erythrocyte cycle ofPlasmodium Jalciparum has been obtained (Trager et al., 
1992; Williams et al., 1995; Trager et al., 1996), the number of merozoites 
completing the cycle is not sufficient to permit continuous extracellular culture. 
Under the best conditions, only 1% of the merozoites further develops into 
trophozoites. Therefore, the isolation of trophozoites still relies on their liberation 
from the host cells. 
Several methods for the isolation of trophozoites had been developed (for review, 
see Hamburger and Kreier, 1980) including: osmotic lysis (Dulaney and Stratman­
Thomas, 1940), ultrasound disruption (Verain and Verain, 1956), the French press 
method (D'Antonio et al., 1966), nitrogen cavitation method (Wallach and Conley, 
1977), mechanical shearing (Heidrich et al., 1979). However, to prepare intact 
trophozoites in high yield and of high purity remains technically difficult. These 
methods either affect the integrity of parasites or fail to remove host materials from 
parasites. 
The most widely used method for freeing parasites from their host cells is the 
saponin lysis (Christopher and Fulton, 1939) but electron microscopy studies have 
shown that these parasites are still trapped within the erythrocyte plasma membrane. 
The most recent procedures include agglutination and lysis by passage through a 
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series of filters (Heidrich et al., 1982), glycerol-enhanced haemolysis (Wunderlich 
et al., 1987), and sorbitol lysis (Hoppe et al., 1992). Isolation ofviable free parasites 
from P. knowlesi-infected erythrocytes has been obtained by nitrogen cavitation 
(Nillni et al., 1985). 
Released parasites need to be further purified from host cell materials, in particular 
erythrocytes and their ghosts, as well as unlysed infected erythrocytes. Published 
methods to achieve this include differential centrifugation (Trager et al., 1990), 
Percoll gr~dient (Wunderlish et al., 1987), Ficoll gradient (Nillni et al., 1985), free 
flow electrophoresis (Heidrich et al., 1982) and chromatography on an 
immunoaffinity column (Hoppe et al., 1992). 
The use of enzyme markers of Plasmodium falciparum and human erythrocytes as 
indicators of parasite purity is well established. The purity of the parasite 
preparation is commonly assayed for the erythrocyte membrane protein, 
acetylcholine esterase (AchE) and the parasite cytosolic protein, lactate 
dehydrogenase (PLDH) in order to evaluate the degree of erythrocyte membrane or 
parasite cytosol contamination, respectively (Vander Jagt et al., 1982). 
Collecting released parasites is only part of the preparation process. The next step 
involves obtaining plasmodial constituents from isolated trophozoites. A certain 
number of techniques have been applied for the disruption of freed parasites, 
including lysis by distilled water (Cook et al., 1971), by Triton X-100 (Sherman et 
al., 1975), by freezing and thaWing (Sherman and Hull, 1960), by sonication (Diggs, 
1966), by homogeneization (Rock et al., 1971), or by treatment with a French 
pressure cell (D' Antonio et al., 1966). 
While methods to isolate host cell ghosts from parasitized erythrocytes have been 
developed (Gruendberg et al., 1983; Wunderlich et a!., 1987), there is no published 
method to isolate the parasite plasma membrane. The isolation of the parasite 
plasma membrane presents technical difficulties due to the presence of three closely 
related membranes, the erythrocyte plasma membrane, the parasitophorous vacuolar 
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membrane (PVM), the endoplasmic reticulum membrane, and the parasite plasma 
membrane (PPM), as well as the food vacuole membrane. An attempt has been 
made to prepare membrane vesicles from parasitized erythrocytes (Herwaldt et al., 
1990); unfortunately these preparations contain membrane elements of both 
parasites and host cells. In this method, disruption of the trophQzoites was achieved 
by nitrogen cavitation and the membranes were separated from parasite lysates by 
discontinuous sucrose gradient centrifugation. 
A number of criteria have to be met when isolating subcellular fractions for 
biochemical experiments. The subcellular constituents have to be pure, intact, 
isolated in high yield and retain their normal physiological capabilities. This chapter 
describes a procedure of parasite plasma membrane isolation from Plasmodium 
Jalciparum-infected erythrocytes without any cross contamination at high yield. In 
this method, the trophozoites released· by saponin treatment were purified from 
erythrocyte membranes using anti-erythrocyte antibodies fixed to polystyrene beads. 
These trophozoites were then biotinylated and the parasite plasma membrane was 
disrupted by nitrogen cavitation. This process allows the membranes to reform into 
vesicles. The magnetic streptavidin beads bind specifically to the biotinylated 
parasite plasma membrane vesicles facilitating their recovery with a magnet. These 
vesicles can then be easily released from the magnetic beads by treatment with 
dithiotreithol, the key steps in the purification are set out in figure 2. 
2.2 Results 
2.2.1 Purification of Plasmodium falciparum trophozoites 
Two methods of lysis for the isolation ofPlasmodium Jalciparum tropho~oites were 
examined. For a detailed description of the method see section 7.2. Briefly, parasites 
synchronised at the trophozoite stage by treatment with 5% sorbitol were released 
from infected erythrocytes either by saponin or sorbitol treatment. Removal of 
erythrocytes was. achieved by immuno-affinity chromatography. The immuno­
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affinity column was prepared with anti-erythrocyte antibodies fixed to polystyrene 
beads. After lysis of the erythrocytes, the protease inhibitors aprotinin, leupeptin and 
phenyl methyl sulfonyl fluoride (PM SF) were added. Unlysed erythrocytes and 
erythrocyte membranes were adsorbed onto the immuno-affinity column. The 
trophozoites were recovered by pelleting. 
2.2.2 Trophozoite purity 
2.2.2.1 Acetylcholine esterase activity of Plasmodium falciparum trophozoites 
Detailed methodology is described in chapter 7, section 5. Acetylcholine esterase 
(AchE) activity of isolated trophozoites was low. AchE activities of trophozoites 
isolated by saponin lysis, sorbitol treatment followed by immunoaffinity purification 
and saponin treatment followed by immunoaffinity purification was 0.14 ± 0.02 
(n=3), 0.08 ± 0.04 (n=3), 0.05 ± 0.01 IlmoVminlmg protein (n=3), respectively. By 
comparison, the specific activity of AchE in erythrocyte ghosts was 2.30 ± 0.15 
IlmoVminlmg protein (n=3) (Table 1). Therefore, trophozoites isolated by saponin 
lysis, sorbitol treatment followed by immunoaffinity purification and saponin 
treatment followed by immunoaffinity purification exhibit 6%, 3.5% and 2% AchE 
activity, respectively, when compared to isolated erythrocyte ghosts. 
The AchE aCtIVIty in the isolated trophozoites differed significantly from 
erythrocyte ghosts AchE activity (p<0.0001). The AchE activity in the trophozoites 
isolated by saponin lysis differed significantly from those further purified by 
immunoaffinity chromatography (p= 0.0091). There is no statistically significant 
difference between the AchE activities in the immunopurified trophozoites isolated 
by sorbitol or saponin lysis (p=0.3659). 
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A 
N-C-SS-Biotin 
B 

N-C-SS-Biotin 

c 

bead 
N-C-SS­
D 
N-C-SS- ] 
magnet 
Figure 2: Isolation ofP. Jalciparum plasma membrane vesicles. (A) Biotinylation of 
the trophozoite membrane with a reversible agent. (B) Disruption of the P. 
Jalciparom plasma membrane by nitrogen decompression. (C) Binding of the 
magnetic streptavidin beads to the biotinylated plasma membrane. (D) Recovery of 
the parasite plasma membrane using a magnet. 
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Table 1. Acetylcholine esterase activity of isolated erythrocyte ghosts and isolated 
J:lq~C>f!i1!"!fa.!.q.ipgr!'/!! ~.rc:lph<?~<?it~~ : ....... .................... '.' ...... ................................ '.' .... . ...... . 
Specific activities (~moVminlmg protein) 
Sample Vander Jagt et al. (1982) This study 
Erythrocyte ghosts 2.30 2.30 ± 0.15 
Trophozoitesa 0.08 
Trophozoitesb 0.0 
TrophozoitesC 0.14 ± 0.02 
Trophozoitesd 0.08 ± 0.04 
Trophozoitese 
... .......................................... ",'...... ".".. . .... ... .... "..".. ....•....• ........ 
a Trophozoites isolated by mechanical rupturing of infected 
differential centrifugation. 
b Trophozoites isolated by free-flow electrophoresis. 
C Trophozoites isolated by saponin lysis . 
0.05 ± 0.01 
. ....... .............~ ,",,' . 
erythrocytes followed by 
d Trophozoites isolated by sorbitol lysis followed by immunoaffinity. 

e Trophozoites isolated by saponin lysis followed by immunoaffinity. 

Values are means ± standard deviation of 3 separate experiments from separate trophozoite 

isolations or erythrocyte membrane preparation. 

2.2.2.2 Parasite lactate dehydrogenase activity of Plasmodium Jalciparum 
trophozoites 
Detailed methodology is described in section 7.6. Parasite lactate dehydrogenase 
(pLDH) activities of trophozoites isolated by saponin lysis was 0.19± 0.05 (n=3) 
whereas those further immunopurified displayed a pLDH activity of 0.14 ± 0.03 
!lmoVrninlmg protein (n=3) (table 2). The pLDH activity in the trophozoites isolated 
by saponin lysis did not differ significantly from those further purified by 
immunoaffinity chromatography (p= 0.8153). 
The pLDH activities of trophozoites were found to be lower in this study than tbose 
measured by Vander Jagt et al. (1982). These trophozoites were isolated by different 
methods and an explanation could be that the plasma membrane become leaky after 
saponin treatment. However, the fact that the trophozoites released by saponin 
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treatment do not concentrate trypan blue indicates that the .n1"'''lTn,h of the plasma 
membrane has been preserved. 

Table 2. Parasite lactate dehydrogenase activity of isolated Plasmodium jalciparum 

Specific activities (Ilmolfminlmg protein) 
This 
Trophozoitesb 3 
TrophozoitesC 0.19 ± 0.05 
Trophozoitesd 0.14 ± 0.03 
by rupturing of followed by 
differential centrifugation. 
b Trophozoites by"""'''''->"'''''' 

C Trophozoites isolated by saponin 

d Trophozoites isolated by saponin lysis followed by imrmmoaffinity. 

Values are means ± standard deviation of 3 separate experiments from separate trophozoite 

2.2.2.3 Sodium dodecyJ sulfate polyacrylamide gel electrophoresis of 
Plasmodium falciparum trophozoites 
Sodium dodecyl sulfate polyacrylamide electrophoresis (SDS-PAGE) of 
erythrocyte ghosts, isolated trophozoites from RSA 11 prepared by saponin lysis, 
sorbitol treatment followed by immunoaffinity purification and saponin treatment 
followed by immunoaffinity chromatography on a 10 % polyacrylamide gel stained 
with revealed no significant erythrocyte membrane protein contamination in 
the tropn~)ZCl1te preparations. The main indicator for erythrocyte contamination is the 
double band of 80-85 Kdaltons molecular weight. Although the pattern was 
could be detected in the various tropn~)ZClnecomplex, no 
preparations. Furthermore, certain bands present in the trophozoites isolated by 
sorbitol or saponin lysis were absent in the trophozoite preparation isolated by 
saporun followed by immunoaffinity chromatography, suggesting that 
additional erythrocyte proteins had been removed this preparation (plate 1). 
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2.2.2.4 Western blot analysis of isolated Plasmodium falciparum trophozoites 
Isolated trophozoite proteins (20llg) from the P. falciparum strain RSAll prepared 
either by saponin treatment followed by immunoaffinity chromatography were 
electrophoresed, transferred onto nitrocellulose and probed with an anti-erythrocyte 
antibody (a-erythrocyte antibody) (detailed methodology in section 7.15). 
Erythrocyte membranes were included in the gel as a control. Separation of 
erythrocyte constituents from the trophozoites was apparent by the visible reduction 
proteins probed by the anti-erythrocyte antibody. No erythrocyte-specific band 
was detected in the trophozoite preparation isolated by saponin lysis followed by 
immunoaffinity purification (Plate 2). 
2.2.3. Trophozoite integrity 
integrity of trophozoites was monitored by measuring the uptake of the 
trypan dye, into the cytoplasm. lOlll of trypan blue (lOmg/ml 
in distilled water) was added to lOOlli of trophozoite suspension in PBS and 
incubated for 5 minutes at room temperature. The proportion of parasites showing 
trypan blue accumulation was evaluated using a phase contrast V''''VIJ''"'. It was 
shown that 98% of the trophozoites released by saponin lysis did not concentrate the 
dye, indicating an intact plasma membrane. 
Recovery of Plasmodium falciparum trophozoites 
An average of 12% ± 8% of trophozoites was recovered from saponin lysis of 
Plasmodium falciparum infected-erythrocytes followed by chromatography using an 
anti-erythrocyte antibody (Table 3). 
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Table 3. Recovery oftrophozoites 
Number of iRBC >I< Number of trophozoites % Recovery 
7.4 x 1 10Ixld;·· 

2 X 108 
 5 
1 X 108 6 
2 X 108 22 
>I< Infected red blood cells 
2.2.5 Plasmodiumfalciparum plasma membrane purification 
a detailed description of the method, see section 7.3 Two different methods 
were used to prepare parasite plasma membranes. In the first method, the parasite 
plasma membrane P. Jalciparum was isolated by fixation on a reversible covalent 
solid support prepared by covalent binding of dithiobis (succinimidylpropionate) 
onto amino-propyl beads. dithio-NHS support bound the 
trophozoites. The remaining sites were blocked by adding The contents of 
the trophozoites were released after lysis by nitrogen cavitation in presence of the 
aprotinin and DnaseI with plasma membrane being 
retained on solid support. In the second method, the trophozoites were 
biotinylated with NHS-SS-biotin prior to nitrogen cavitation in presence of the 
protease inhibitor aprotinin Dnase!. resulting biotinylated membranes 
bound streptavidin-magnetic beads and were separated the lysate by lJa~'"al';" 
through a magnetic column. The membrane vesicles were collected by simply 
removing the magnet from the column. In both methods, membranes were eluted 
using dithiothreitol. 
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2.2.6 Parasite plasma membrane purity 
2.2.6.1 Acetylcholine esterase activity of Plasmodium Jalciparum plasma 
membrane 
Detailed methodology is described in section 7.5. There was no detectable AchE 
activity (less than O.OIllmoVrninfmg protein) in the parasite plasma membrane 
preparations (n=3). By comparison, the specific activity of AchE was ± 0.15 
and 0.05 ± 0.03 IlmoVrninfmg protein in erythrocyte ghosts and isolated trophozoites 
(n=3) (Table 4). 
Table 4.Acetylcholine 
Plasmoqil!.l1lfCl!c.ipCl~ul71 
Samples 
esterase actIvIty of isolated 
and isolated 
erythrocyte ghosts, isolated 
membranes. 
Specific activities 
(IlmoVrninfmg protein) 
2.30 ±0.15 

Trophozoites 0.05 ± 0.03 
Vesicles prepared by fixation onto dithlobis-coated beads No activity 
Vesicles prepared by fixation onto magnetic beads No activity 
Values are means ± deviation of 3 separate experiments separate parasite 
plasma isolations, trophozoite isolations or erythrocyte membrane preparation. 
2.2.6.2 Parasite lactate dehydrogenase activity of Plasmodium Jo1ciparum 
plasma membrane 
To investigate whether the parasite plasma membranes were contaminated by 
cytosolic the pLDH activities of the various preparations were 
determined. Detailed methodology is described in section 7.6. There were no 
detectable pLDH activity (less than 0.0 IllmoVminfmg protein) in the parasite 
plasma membrane preparations (n=3). By comparison, the specific activity 10 
isolated trophozoites was 0.14 ± 0.01 IlmoVrninfmg protein (n=3) (Table 5). 
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Table 5. Parasite lactate dehydrogenase activity of isolated Plasmodium Jalciparum 
trophozoites and isolated parasite plasma membranes . 
. .. . . ................ .. ............... .......•............................ ............. ........ .... ............ .......•'.'.., ..... .. ............... . ..................................... ............................ ,-......••.. ....... ..............•... ., --...... . .... . ... ... .... . ... .... .... . .. ... .. . 
Specific activities 
Samples (/lmollminlmg protein) 
Trophozoites 0.14 ± 0.01 
Vesicles prepared by fixation onto dithiobis-coated beads No activity 
Vesicles prepared by fixation onto magnetic beads No activity 
. ............................... .... ... . ·.·.·..·.· .·.·.·.· .·.·.·N.· .·.·.· .·/ . .................... ........................................ ... . .. ................. ..... ... ........................ , ....•...... .. ......... . .. .................... .. ... ........•.... .... .... ............•.. ....~ .. .... .....•...... . 

Values are means ± standard deviation of 3 separate experiments from separate parasite 
plasma isolations or trophozoite isolations. 
2.2.6.3 Microscopic examination of Plasmodium falciparum plasma membrane 
Homogenous preparations of purified Plasmodium Jalciparum plasma membranes 
were examined using phase contrast microscopy (plate 3) and transmission electron 
microscopy (plate 4) . No visible contamination by other membranes or organelles 
was observed, although some liberated hemozoin crystal could occasionally be seen. 
Similarly, no visible contamination of the trophozoites preparations was observed 
using phase contrast microscopy (plate 5) and transmission electron microscopy. A 
transmission electron micrograph of an isolated P. Jalciparum trophozoite is shown 
in Plate 6. For comparison, a trophozoite-infected erythrocyte can be viewed using 
phase contrast microscopy (plate 7) and transmission electron microscopy (plate 8). 
2.2.6.4 Sodium dodecyl sulfate polyacrylamide gel electrophoresis of 
Plasmodium falciparum plasma membrane 
Trophozoites, food vacuoles and parasite plasma membranes isolated from the 
Plasmodium Jalciparum strains DlO and RSAll along with erythrocyte membranes 
as a control were examined by SDS-PAGE. No visible contamination by food 
vacuole or erythrocyte proteins was observed in the parasite plasma membrane 
preparations; bands present m the lane containing the food vacuoles or the 
erythrocytes were absent in the lane containing the parasite plasma membranes 
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(Plate 9). Specific band intensities were found to be quite different in the lanes 
containing the plasma membranes isolated from the P. jalciparum strains D 1 0 and 
RSAII which could suggest a differential protein content in these 2 strains. 
2.2.7 Parasite plasma membrane integrity 
Purified Plasmodium jalciparum plasma membranes examined using transmission 
electron microscopy were observed to form intact vesicles although some open 
membranes could be seen (Plate 4). These vesicles were found to have an average 
diameter of 500 nm. 
2.2.8 Recovery of Plasmodium Jalciparum plasma membrane 
An average of 8.2 % ± 6.1 (n=5) and 5.5 %± 1.3 (n=4) of trophozoite protein was 
recovered from nitrogen cavitation of isolated trophozoites linked to magnetic beads 
and dithiobis-coated beads, respectively (Table 6). 
Table 6: Recovery of Plasmodium faIciparum plasma membranes. 
Samples % Recovery 
Vesicles prepared by fixation onto dithiobis-coated beads 5.5 ± 1.3 (n=4) 
Vesicles prepared by fixation onto magnetic beads 8.2 ± 6.1 (n=5) 
. . ......... . .. . .... " .. 

Recovery is expressed by protein determination and represent percentage of trophozoites. 
Values are means ± standard deviation of separate experiments from separate parasite 
plasma isolations. 
2.3 Discussion 
A procedure for parasite plasma isolation from Plasmodium jalciparum-infected 
erythrocytes was developed. Membrane vesicle preparations contained 8.2% of the 
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total trophozoite protein. result is consistent with the percent protein yield (8­
10%) obtained for membrane vesicles prepared from cancer (Cornwell et aI., 
1986). Interestingly, SDS-PAGE analysis revealed a differential protein content 
between plasma membranes isolated from the Pjalciparum strains D 10 and F ac8. 
However, these should confirmed on a larger of m to 
investigate an eventual correlation between specific band intensities and the resistant 
phenotype. 
In this method, trophozoites were released from the erythrocytes by saponin lysis, 
the remaining erythrocytes membranes being removed by immunoaffinity 
chromatography using anti-erythrocyte antibodies. Previously, anti-erythrocyte 
monoclonal have been to remove unlysed erythrocytes and ghost 
membranes (Hoppe et al., 1 However, in order to remove most of the 
erythrocyte ghosts by centrifugation, all the erythrocytes must be lysed by the 
detergent therefore allowing isolation of the trophozoites in a scale. Only 
parasitized erythrocytes were lysed with sorbitol while non-infected remained intact. 
On the other hand, saponin lysed uninfected and infected erythrocytes. this 
reason, trophozoites released by sorbitol lysis were not retained in this study to 
further purifY the plasma membranes. Futhermore, saponin-treatment of parasitised 
erythrocytes has been shown to permeabilise both the erythrocyte plasma membrane 
and parasitophorous membrane (Ansorge et aI., 1996; 1997). However, 
contamination of the plasma membrane vesicle preparations by the parasitophorous 
membrane could not be discounted since there is no specific marker for this 
membrane to our knowledge. 
Evidence for the membrane of saponin-freed parasites came studies 
measuring the rate of incorporation of e4C]-isoleucine into protein (Saliba and Kirk, 
1999) and the rate of phosphorylation of the pantothenic acid (Saliba et aI., 1998). 
In this study, experiments with the trypan blue showed that 98% of the trophozoites 
released by saponin lysis were capable ofmaintaining an intact plasma membrane. 
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Nitrogen decompression has been previously shown to be effective for the 
disruption of cells and was used in this study to disrupt the parasite plasma 
membranes (Cornwell et al., 1986). When membranes bound to the dithiobis support 
were recovered by centrifugation, food vacuoles and hemozoin were found to pellet 
along with the membranes, making their purification difficult. Furthermore, 
fragments of glass were observed in the samples examined by transmission electron 
microscopy indicating that some of the glass beads had broken during the nitrogen 
cavitation step. Therefore, this method was abandoned as a means of membrane 
purification. Alternatively, biotinylated membranes bound to streptavidin-magnetic 
beads recovered using a magnet were shown to be free of food vacuole 
contamination. The fact that the membranes were bound to a support facilitated their 
purification contaminants and Another advantage of this 
technique is that only the plasma membrane vesicles formed the way round 
will be recovered. 
A cocktail of protease inhibitors (aprotinin, leupeptin and was used to 
prevent the degradation of membrane proteins by the proteases released during the 
nitrogen cavitation step. The of DNA presents an additional problem, as 
the parasites adhere to the sticky DNA liberated during parasite lysis. I was, 
therefore, included in the isolation process to eliminate the DNA liberated during the 
nitrogen cavitation step. 
Purified Plasmodium Jalciparum plasma membranes examined using transmission 
electron microscopy were observed to intact and free of contaminating 
membranes and organelles even though small amount of liberated haernozoin could 
occasionally be seen in certain fields. The isolation of individual plasma membrane 
vesicles was difficult since these vesicles tended to be aggregated and formed sheets 
as shown plate 4. The of parasite cytosolic and erythrocyte in the 
parasite plasma membranes preparation was confirmed by non-detectable parasite 
lactate dehydrogenase and erythrocyte acetylcholine esterase activities. Further 
....."',,,..,'" for the absence erythrocyte parasite plasma memDjra 
preparations carne from SDS-P AGE analysis and western blot analysis with an anti­
36 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter of trophozoites and plasma membranes 
erythrocyte antibody. method of parasite plasma membrane isolation 
improvement the Herwaldt et (1990) 
method used to prepare melmOlra vesicles infected-erythrocytes. 
presented in this thesis rprlrp<~pntc 
2.4 Conclusion 
A method has developed for the preparation of Plasmodium Ja/Ciparum plasma 
membrane vesicles. These isolated membranes were intact and isolated in a high 
enough yield to enable a characterisation of their ATPase activities and an 
investigation of their drug transport properties. 
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Plate 1: SDS-PAGE of 20~g isolated RSAlltrophozoite protein released by 
sorbitol lysis followed by immunoaffinity purification, saponin lysis and saponin 
lysis followed by immunoaffinity purification; lane I, 2, 3, respectively, compared 
to lO~g of erythrocyte membrane protein, lane 4. Lane 5 contains protein markers 
with approximate molecular weight expressed in kDa. 
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Plate 2: The protein of 20~g isolated RSAl1 trophozoites released by saponin lysis 
followed by immunoaffinity purification (lane 3), and IO~g of erythrocyte 
membrane protein (lane 2) were separated by SDS-PAGE transferred to 
nitrocellulose, probed with a-erythrocyte antibodies and recognised bands detected 
colorimetrically. Lane 1 contains protein markers with approximate molecular 
weight expressed in kDa. 
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Plate 3: Phase contrast micrograph of purified Plasmodium falciparnm plasma 
membranes 
Plate 4: Transmission electron micrograph of purified Plasmodium falciparum 
plasma membranes (magnification x25,OOO). 
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Plate 5: Phase contrast micrograph of purified isolated Plasmodium jalciparum 
trophozoites 
Plate 6: Transmission electron micrograph of isolated Plasmodium jalciparnm 

trophozoites (magnification x 10000). 
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Plate 7: Phase contrast micrograph of erythrocytes infected with Plasmodium 
falciparum trophozoites. 
Plate 8: Transmission electron micrograph of erythrocytes infected with 
Plasmodium falciparum trophozoites (magnification xIO,OOO). 
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Plate 9: SDS-PAGE of 2011g of isolated RSAll plasma membrane protein, food 
vacuole protein and trophozoite protein; lane 1, 2, 3 respectively; 50~g of isolated 
D 1 0 plasma membrane protein, food vacuole protein and trophozoite protein; lane 4, 
5, 6 respectively; and l011g of erythrocyte membrane protein, lane 7. Lane 8 
contains protein markers with approximate molecular weight expressed in kDa. 
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CHAPTER 3 
Characterisation of Plasmodium /alciparum plasma 
membrane ATPase activity 
3.1 Introduction 
The aminoacid sequence of Pgh1 indicates two consensus sequences for ATP 
binding (Foote et al., 1989) and ATP has been shown by photoaffinity-labeIling 
studies to bind to Pghl (Karcz et al., 1 993b), suggesting that Pghl may act as 
transport ATPase. In addition, the malaria parasite has been shown to posses a V­
type ATPase (Bray et aI., 1992b) and two subunits of this ATPase have been cloned 
(Karcz et aI., 1993a; 1994). Indirect immunofluorescence studies revealed the 
presence of this ATPase over most of the parasite during the trophozoite and sruzont 
stages (Karcz et aI., 1994). This heterogenous distribution lead to the proposal that 
the function of this V-ATPase is not confined to the regulation of the pH of 
digestive vacuoles. 
A V-type ATPase (Karcz et al., 1994) and a P-glycoprotein homologue (Pgh1) 
(Cowman et al., 1991) have been reported to be located in the food vacuole and the 
plasma membrane of Plasmodium Jalciparom and have been identified as potential 
sites involved in the mechanism of chloroquine-resistance. Although the 
Plasmodium Jalciparom vacuolar ATPase activity have been characterised (Choi 
and Mego, 1988), the ATPase activity of the parasite plasma membrane has not yet 
been investigated. In cancer cells, the MDR phenotype is believed to be the result of 
the expression of a P-glycoprotein in the plasma membrane (Gottesman and pastan, 
1993; Gottesman et al., 1995) and this molecule has been shown to possess drug­
stimulated ATPase activity (Chang et ai., 1997). It is the aim of this chapter to 
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evaluate the dependence Plasmodium Jalciparum plasma membrane ATPase 
activity on A TP and other nudeotides, divalent cations, time, A TP and Mg2+ 
concentrations, and to compare the ATPase activity of plasma membranes isolated 
from two chloroquine-sensitive strains and three chloroquine-resistant strains. 
ATPases have been classified into three major groups, namely P-type 
which form phosphorylated intermediates during their reaction cycle, the V -type 
ATPases found in vacuoles and the F-type ATPases primarily used in ATP synthesis 
(pedersen and CarafoIi, 1987). ion-motive can be 
distinguished according to their relative to inhibitors. Vanadate is 
believed to inhibit P-type ATPases by preventing the formation of a phosphoaspartyl 
intermediate. Ouabain is a specific inhibitor of the Na +/K+-ATPases while the 
sulfhydryl reagent N-ethylmaleimide and oligomycin are known inhibitors of the 
proton pump and the mitochondrial membrane r spectively. the 
specificity of these inhibitors has been questioned vanadate has been shown to 
inhibit non-P-type-membrane-associated ATPases (Prossnitz et al., 1989) and 
has been reported by Hamada and Tsuruo (1988) to inhibit P-glycoprotein ATPase 
activities. Nevertheless, bafilomycin Al is believed to a high-affinity inhibitor of 
V-ATPases (Bowman et al., 1988). In order to identifY the type of present 
in the parasite plasma membrane, the effect of these inhibitors on the Plasmodium 
Jalciparum plasma will be studied. The concentrations the V -type and 
P-type ATPase inhibitors tested in this study were similar to those chosen by Choi 
and Mego (1988) to investigate their effect on the plasmodial food vacuole ATPase 
activity. 
Chloroquine in Plasmodium Jalciparum can be reversed by a certain 
number of chemically distinct compounds (Martin et ai., 1987; Krogstad et ai., 
1987a). It is difficult to predict how chemosensitisers might affect the ATPase 
activity of the parasite plasma the mechanism by which they 
reverse chloroquine resistance is unknown. Moreover, their mode of action might 
vary depending the type chemosensitiser. three chemosensitisers chosen in 
study belong to of compound to multi drug 
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resllstrunce cells to chemotherapeutic agents cancer cells (Georges et 
al., 1990). These include the calcium cmmnel blocker verapamil, the calmodulin 
inhibitor trifluoperazine rund the steroid hormone prc)gesteron 
Na+JIr exchrunger (NHE) has been ""...~,n",,1'1 on Plasmodium falciparum plasma 
membrane (Bosia et aI., 1993) ''''''''lCiV,,'U to regulate the parasite's 
cytosolic pH. Latter studies sug;ges.tea that plasmodial NHE facilitates the import 
of chloroquine (Sanchez et that an NHE is responsible for the 
phenomenon of chloroquine ",,,"n""'l"'''' (Wunsh et aI., 1998). These proposals were 
based on studies using the amiloride derivatives known as specific inhibitors 
of the NHE rund have cnanengea (Bray et al., 1999; Saliba rund Kirk, 
1999). In this study, the amiloride, rund its derivatives dimethylamiloride 
(DMA) rund 5-(N-ethyl-isopropyl) amiloride (EIPA) on the ATPase activity of 
Plasmodium falciparum plasma melmlJlrrunc~s isolated from a chloroquine-sensitive 
rund a chloroquine-resistant be observed. 
Finally, the effect of runtimalrurials quinine, mefloquine rund artemisinin on the 
Plasmodium falctparum ATPase activity will be examined to 
determine run 1:"-(]lepCen(]lem trrunsport of these drug occurs at 
membrane level regulation of the by 
the trrunsported a rund in a 
strain. 
3.2 Results 
3.2.1 Time-dependence of the ATPase activity in Plasmodium Jalciparum 
plasma 
For a detailed of the assay, see section 7.10. of the 

ATPase activity membranes isolated from the rtarsm,oaJum falciparum
1.111.1.."11'" 
strain 10 was ,",VClCluaL,",U over a time period of 45 minutes. relationship of 
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time versus ATPase activity was found with a correlation coefficient of 0.717 
(n=3)(Figure 
a 
E
-c:: 
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Figure 3: course of 10 plasma membranes ATPase activity (omol Pilmg 
protein) over a time period of 45 minutes. ATPase activity of parasite plasma 
membranes tested without was subtracted. Errors bars represent standard 
deviations means separate experiments, each performed in quadruplicate. 
Nucleotide-dependence of the ATPase activity in Plasmodium Jalciparum 
plasma membranes 
The ability of 2mM concentrations of and other nucleotides to support the 
ATPase activity of plasma membranes isolated from the Plasmodium falciparnm 
strain D 1 0 was investigated. Other nucleoside triphosphates namely 
guanosine triphosphate (GTP), cytosine triphosphate (CTP), and uridine 
triphosphate (UTP) were hydrolysed as effectively as while 6.7% and 
7.1 % of the nucleoside diphosphates, adenosine diphosphate (ADP) and 
guanosine diphosphate (GDP) were hydrolysed. Only adenosine monophosphate 
(AMP) was not hydrolysed by the DIO membranes (Table 
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Table 7: ATPase activity of isolated D 10 plasma membranes in the presence of 
2mM concentrations of various nucleotides. 
. ....... ......................, ..........•.......... ..... '..............,.... '.............'.................. .. ........... '............,.... . 

ATPase activity (% of control) 
Nucleotide Triphosphate Diphosphate Monophosphate 
Adenosine 100 72.6±16.7 -9.2±9.3 
Guanosine 120.8±19.6 55.4±17.1 N.D . 
Cytosine 64.2±7.6 N .D. N.D . 
Uridine 101.4±55.0 N .D. N.D. 
.·.·.·.·.·N _.'." ·.·.·u.·.·.·· . '.". ".-." ..... .... .. , . .. ..... .. ................ , . . .... , •..... ·-.- ....n ,.'", .... ..,..................... . . ., . .......... '." .........~. '.'... . ......•~ ..... '" 

Values are means of 3 separate experiments, each performed in quadruplicate ± standard 
deviations and are expressed as % of control in presence of ATP. ATPase activity tested 
without nucleotide and absorbance due to the nucleotide hydrolysis was subtracted. N.D.: 
not determined. 
3.2.3 Effect of ATP concentration on the ATPase activity in Plasmodium 
/alciparum plasma membranes 
The ATPase activity of D 10 plasma membranes was evaluated over a range of 
increasing ATP concentrations from 0.5 to 5mM, at a fixed Mg2+ concentration of 
2mM. The ATPase activity was 3.96±0.84nmol Pi/min/mg protein in presence of 
2mM ATP and no appreciable increase was observed with higher ATP 
concentrations (Figure 4). 
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Dependence of ATPase ATPase activity of 
1 0 plasma membranes as nmol Pilminlmg was 
measured over ATP concentrations ranging from 0.5 to ATPase activity of 
parasite plasma membranes tested without ATP and absorbance due to ATP 
hydrolysis was subtracted. Data for Michaelis Menten curve was fitted using 
GrapbPad Prism (GrapPad Software) the substrate concentration at which half 
the velocity occurs mM) maximal velocity (Vm=5nmol Pilminlmg) was 
determined from the curve. bars represent standard deviations from means of 
3 separate experiments, each performed in quadruplicate. 
3.2.4 Divalent cation-dependence of ATPase activity in Plasmodium 
falciparum plasma membranes 
The ability of 2mM concentration of Mg2+ and other divalent cations Mn2 + and 
Ca2+ to support the ATPase '::'('T1U.lr'l purified plasma membranes isolated from 
Plasmodium Jalciparom strain D 1 0 was evaluated, along with no divalent cation 
addition as a control. Maximal ATPase was obtained in presence of 2mM 
. A significant activity (87.8±33.1%) was when Mg2+ was replaced 
was substituted for Mg2+, only 9.2% of the ATPase 
"'''''''''"1'''' was retained (Table 8). 
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Table 8: Effect divalent cations on purified DIO plasma membranes ATPase 
2
activity. ATPase activity was determined using 2mM concentration of Mg +, Mn2+ 
and Ca2+. activities are expressed as percentages ofcontroL 
Cations 
2 100 
2 1 
2 20.9±19.2 
Plasma membrane actlVlty in absence of was subtracted. Errors 
bars represent standard deviations from means of 3 separate experiments, each performed in 
quadruplicate. 
3.2.5 Effect of Mg2+ concentration on the ATPase activity in Plasmodium 
Jalciparum plasma membranes 
The activity of D 1 0 plasma membranes was alU(U~,U over a from 0 
to 5mM of Mg2+ concentrations. optimal ATPase "' ........nrn..u of 3 .59nmol 
Pilminlmg protein was achieved 2mM Mg2+ (Figure 5). 
5~-------------------------------------, 
o~----~----~------~----~----~----~ 
o 1 2 3 4 5 6 
Mg2+ (mM) 
Figure Dependence of ATPase activity on concentration. actIVIty 
of freshly purified D 1 0 plasma membranes expressed as nmol Pilminlmg protein 
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was measured over Mg2+ concentrations ranging from 0 to 5mM. ATPase activity of 
parasite plasma membranes tested without ATP and absorbance due to A TP 
hydrolysis was subtracted. Errors bars represent standard deviations from means of 3 
separate experiments, each performed in quadruplicate. 
3.2.6 ATPase activity of parasite plasma membranes isolated from chloroquine­
resistant and -sensitive strains of Plasmodiumfalciparum 
The ATPase activity of parasite plasma membranes isolated from different strains of 
Plasmodium falciparum exhibiting various degrees of chloroquine resistance was 
evaluated. Purified parasite plasma membranes isolated from the sensitive strains 
DIO and RSA3 displayed an ATPase activity of 3.25±1.75 and 4.I7±2.09runol 
Pi/min/mg protein, respectively, while those isolated from the chloroquine-resistant 
strains Fac8, RSAII and KI displayed an activity of I1.90±I.46, IO.05±O.79 and 
5.8I±O.66runol Pi/min/mg protein, respectively (Figure 6). ATPase activities of 
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Figure 6: ATPase actiVIty (runol Pi/min/mg protein) of parasite plasma 
membranes isolated from the Plasmodium falciparum strains DIO, RSA3, Fac8, 
RSA11 and K 1. ATPase activity of freshly purified parasite plasma membranes 
was determined using 2mM ATP and 2mM Mg2+. ATPase activity of parasite 
plasma membranes tested without ATP and absorbance due to ATP hydrolysis 
was subtracted. Errors bars represent standard deviations from means of 3 
separate experiments, each performed in quadruplicate. 
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parasite plasma membranes isolated from the chloroquine-sensitive strains D 1 0 and 
RSA3 were found to be significantly to those membranes isolated 
from the resistant strains Fac8, RSAll and with p values <0.0001 for all the 
sensitive and resistant strains compared, except for RSA3 and KI 72). 
3.2.7 Effect of P-type ATPase inbibitors on Plasmodium /alcipa11lm plasma 
membranes ATPase activity 
Ouabain (lmM), a Na+/K+-ATPase inhibitor had no significant effect on DlO 
and plasma membrane ATPase activities with p values of 0.3019 and 0.2930, 
respectively. Oligomycin (50J.!glml) inhibited the ATPase activity of membranes 
purified from P. Jalciparum strains Fac8 by (p=0.0126), and 
effect on 0 membrane ATPase activity (p=0.0462), while vanadate 
(0.1mM) inhibited by (p=0.0337) and 29±14% (p=0.0499) the ATPase 
activity of purified plasma membranes from the P. Jalciparum strains D 1 0 and F ac8, 
respectively (Figure 7). There is no statistically significant between 
activity of membranes purified from the Jalciparum strains Fac8 and DIO 
in the ofvanadate (p=0.4606) or oligomycin 
The presence of dimethylsulfoxide (DMSO), used to solubilise ouabain and 
oligomycin at a final concentration of 0.5 0.2%, respectively, had no effect on 
the parasite plasma membrane ATPase activity (data not shown). 
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Figure 7: Effect of the P-type ATPase inhibitors vanadate (0. ImM), oligomycin 
(50J.lglml) and ouabain (lmM) on the ATPase activity of parasite plasma 
membranes isolated from the Plasmodiumfalciparnm strains DIO and Fac8 . ATPase 
inhibitors were added to the assay I5-min. prior to the addition of ATP. Values are 
expressed as percentages of controls without drugs and error bars represent standard 
deviations from means of 3 separate experiments, each perfonned in quadruplicate. 
3.2.8 Effect of V-type ATPase inhibitors on Plasmodium falciparum plasma 
membranes ATPase activity 
Bafilomycin Al (l J.lM), a high-affinity inhibitor of V -ATPases and N­
ethylmaleimide (NEM) (2mM) inhibited D 1 0 plasma membrane ATPase activities 
by 47±22 (p=O.OIOI)and 32±22% (p=0.3040), respectively, while these inhibitors 
decreased Fac8 plasma membrane ATPase activities by I7± 14 (p=0.I637) and 14± 
20% (p=0.3063), respectively (Figure 8). There is no statistically significant 
difference between the ATPase activity of membranes purified from the P. 
falciparnm strains Fac8 and DlO in the presence of Bafilomycin Al (p=0.0970) or 
N-ethylmaleimide (p=0.3691).The presence of dimethylsulfoxide (DMSO), used to 
solubilise bafilomycin Al at a final concentration of 0.1 % had no effect on the 
parasite plasma membrane ATPase activity (data not shown). 
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Figure 8: Effect of V-type inhibitors Bafilomycin (1 !lM), and 
ethylmaleimide (NEM) (2rnM) on the ATPase activity of parasite plasma 
membranes isolated from the Plasmodium Jalciparum strains 10 and Fac8. ATPase 
inhibitors were added to assay IS-min. prior to the addition of ATP. Values are 
expressed as controls in the absence of and error bars n"n,r.."pnT 
standard deviations from means of experiments, each performed in 
quadruplicate, Number of experiments is indicated above the bars, 
3.2.9 Effect of N a +m+-exchanger inhibitors on Plasmodium falciparum plasma 
membranes activity 
Arniloride and its have been shown to inhibit the activity of eukaryotic 
et al. (1997)at micromolar concentrations and 
demonstrated that the half-maximal inhibition of cWoroquine uptake was achieved at 
an EIPA concentration of6.2IlM for and 621lM Dd2. Therefore, the effect 
of the Na+M-exchanger inhibitors amiloride, dimethylamiloride (DMA) and S-(N­
ethyl-isopropyl) arniloride (EIP A) on P. Jalciparum plasma membrane activity was 
determined at a 1001lM concentration. Arniloride (lOOIlM) stimulated the plasma 
membrane ATPase activity D 10 and Fac8 to 3I7±62% 169±36%, 
respectively while derivative DMA (1001lM) had a stimulatory 
and 1 on DlO Fac8 plasma membranes, respectively. The 31 
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more potent NHE inhibitor, EIPA (100~) increased the ATPase activity of DIO 
and Fac8 plasma membranes by 209±40% and 123±21%, respectively (figure 9). 
The effect of the Na +,If-["-exchanger inhibitors on D 1 0 and Fac8 plasma membrane 
ATPase activity was found to statistically significant with p values <0.0001 for the 
effect of amiloride and DMA on both strains while p=O.0013 and 0.0050 for the 
effect of EIP A on D 10 and F ac8, respectively. There is a statistically significant 
difference between the ATPase activities of parasite plasma membranes isolated 
from the chloroquine-sensitive and -resistant strains of P jalciparum measured in 
the presence of all the Na+,If-["-exchanger inhibitors tested with p values <0.0001. 
400.----------------------------------------------. 
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> ;; 300 (.) 
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Figure 9: Effect of the NHE inhibitors amiloride (100~), DMA (100~ and 
EIP A (1 OO~) on the ATPase activity of plasma membranes isolated from the P. 
Jalciparum strains DI0 and Fac8. NHE inhibitors were added to the assay 15 min. 
prior to the addition of ATP. Values are expressed as percentages of controls 
without drugs and error bars represent standard deviations from means of 3 separate 
experiments, each performed in quadruplicate. 
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3.2.10 of chemosensitisers on Plasmodiumfalciparum plasma membranes 
A TPase activity 
Verapamil (1 trifluoperazine (lO~) and progesterone (lOOfl.M) had little or 
no effect on the parasite plasma membrane A TPase Of the 
tested, trifluoperazine (1 O~) and nr....,o"'c't"'r,....np (lOOfl.M) inhibited 
D 1 0 plasma membrane ATPase activities by respectively 
(Figure 10), There were no statistically slgrunlCaJf1I effect the chemosensitisers 
on Jalciparum plasma membranes ATPase activities p values 
The presence ethanol used to solubilise progesterone at a final concentration of 
0.25% no on the parasite membrane ATPase (data not 
shown). 
o...J.-.~=-"'; 
Verapamil Trifluoperazine Progesterone 
Figure 10: Effect the chemosensitisers O~), (l01lM) 
and progesterone (l001lM) on the actlVlty parasite plasma membranes 
isolated from the Plasmodium Jalciparum strains DIO and Fac8, Chemosensitisers 
were added to the 15 min, prior to the addition of ATP. are 
as percentages controls without drugs error bars represent standard deviations 
from means of 3 each performed in quadruplicate. 
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3.2.11 Effect of anti-malarials on Plasmodium Jalciparum plasma membranes 
A TPase activity 
The antimalarial meiloquine (lmM) inhibited the ATPase activity of ""'''''mh'-'' ...... " 
purified from Plasmodium Jalciparum strains D10 and F ac8 by 21 ±17 
(p=0.0438) and (p <0.0001), respectively, while quinine (0.1mM) inhibited 
by 16±14 (p=O.0806) and 29±20% (p<O.OOOl) the ATPase of purified 
plasma membranes from the Plasmodium Jalciparum strains DIO and Fac8, 
respectively. Artemisinin (lmM) inhibited by II % (p=O.0890) and 4 ±24 % 
the ATPase activity of purified plasma membranes from the 
Plasmodium Jalciparum strains 0 and Fac8, respectively (Figure 11). There were 
no statistically significant difference between ATPase activities of parasite 
plasma membranes isolated from the chloroquine-sensitive and -resistant of 
P jalciparum measured in the presence of quinine and artemisinin with p values of 
0.0743 and 0.3219, respectively, while the effect of meiloquine was found to be 
statistically significant with a p value of0.0055. 
presence of dimethylsulfoxide (DMSO), used to solubilise meiloquine at a final 
concentration of O. 1 % had no effect on the parasite plasma membrane ATPase 
activity (data not shown). The antimalarial chloroquine available in our laboratory 
was a diphosphate salt and could not therefore be included in this assay which is 
based on colorimetric determination ofphosphate. 
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Figure 11: Effect of the (O.lmM) and 
artemisinin (lmM) on the of parasite membranes isolated 
from the Plasmodium Jalciparum strains D 1 0 and Antimalarials were added to 
assay 15 min. prior to the addition of Values are as per'ceruaJ~es 
of controls in the of the drugs and error bars standard deviations 
from means 3 separate each performed in quadruplicate. 
3.3 Discussion 
Conditions required optimal Plasmodium Jalciparum plasma membrane ATPase 
activity were determined using chloroquine-sensitive D10. 
membranes showed optimal ATPase activity at 2mM Mg2+ and 2mM ATP. Other 
divalent cations are able to substitute for and maintain the function of a variety 
different (Doige et aI., 1992). this it was found that could 
not substitute for Mg2+ ATPase activity in parasite plasma membranes, whereas 
activity was preserved when Mn2+ was substituted for 
plasma membrane ATPase activity was found to be similar to vacuolar 
membrane ATPase activity (Adams, 1999) However, This contradicts Choi and 
Mego (1988) study showing that could the Plasmodium Jalciparum 
activity in absencevacuolar 
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Table Chloroquine sensitivity and activity (nmol protein) of 
parasite plasma membranes isolated from the Plasmodium Jalciparum strains D 1 0, 
RSAll and Kl. 
IC50 ATPase 
Pi/minlmg protein) 
10 28.32±3.53 3 .75 
RSAJ 52.46±17.01 4.1 
Fac8 157.50±55.98 11.90±1.46 
RSA11 
Kl 379.10±34.96 5.81±0.66 
3 separate experiments ± standard deviation. 
Other nucleoside triphosphates tested were hydrolysed as effectively as 
suggesting that parasite plasma contains a nucleotide triphosphate 
hydrolase, rather than a specific However, the nucleoside monophosphate 
was not hydrolysed suggesting that the parasite plasma membrane ATPase 
activity is distinguishable from membrane-associated alkaline and acid phosphatases 
(Ketcham et at., 1985). Although no linear relationship was observed between the 
level of activity and chloroquine sensitivity, plasma membranes isolated from 
the chloroquine-sensitive strains of P. Jalciparum presented a lower level of ATPase 
activity than resistant counterparts (Table 9). This result could be consistent 
with the of an overexpressed A TP-driven drug exporter in the plasma 
membrane of resistant strains of Jalciparum. The lack of correlation observed 
between the ATPase activity in the parasite plasma and ICso 
P.falciparum strains tested could be due to the use of as opposed clones and 
it would therefore be interesting to confirm this result on a larger number ofclones. 
ATPase actiVIty of parasite plasma membranes was found to be of similar 
magnitude to that of cancer cells. comparison, the specific activity of 
plasma membranes prepared from multidrug-resistant cancer is 
1.15J.l.mollminlmg membrane protein (Rebbeor et 1998). parasite 
plasma memora were isolated in the form of intact """,1"" the right -side-out, the 
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hydrolysing regIOns the ATPase proteins should be enclosed within the 
vesicles arising question whether all of the compound tested are access 
to the part of protein, and whether the differences the ATPase 
measured the presence of agents might at to 
some extent, the different ability of these agents to gain access to interior of the 
vesicles. Therefore, it could not be excluded that the saturable dependence of 
ATPase activity on the concentration of A TP in the medium could reflect the 
saturable transport of ATP into the vesicles, rather than the the ATPase 
itself Similarly, the differential ability divalent to support ATPase 
activity could result of a differential transport of these cations into the vesicles. 
Pghl, a ..._...."no ATPase was identified on the Jalciparom plasma and vacuolar 
membrane and was believed to play a role in both mechanism of chloroquine 
accumulation and chloroquine-resistance (Cowman et , 1991). Whether Pghl 
transports chloroquine or controls its uptake through regulation of the intravacuolar 
pH by a chloride channel activity is still subject of controversy. In this study, the 
effect of P -type inhibitors on the ATPase activity of plasma membranes was 
observed in order to determine their participation in the ATPase activity u ....."".. " ... 
Vanadate reduced the plasma membrane activity of the Jalciparum strain 
DlO and Fac8 by 41% and 28%, respectively, therefore implicating a P-type 
component in the activity observed since V-ATPases are not sensitive to 
vanadate (Mellman el at., 1986). Furthermore, the inhibition of 
activity by oligomycin would be with possible higher levels of Pgh 1 In 
Fac8 (Cowman et al., 1991) since this inhibitor has been shown to inhibit P-gp 
homologues (Me Kinney and Hosford, 1993; Decottignies et 1994). Ouabain 
no effect on the plasmodial plasma membrane ATPase activity indicating that the 
Jaiciparum plasma membrane does not contain an ouabain-sensitive Na+/K +­
ATPase. 
Many compounds that reverse MDR in cultured have identified. These 
chemosensitisers were shown to have a stimulatory on P-glyeoprotein 
activity in plasma membranes (Rao et al., 1994; Sarkadi et al., 1994; Scarborough, 
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1995), in Pgp reconstituted in liposomes (Rebbeor and Senior, 1998) and purified 
glycoprotein (Doige et at., 1992). Similarly, chloroquine resistance can be reversed 
by chemosensitisers such as verapamil (Martin et at., 1987). In this study, none of 
the chemosensitisers tested had an effect on the activity of the parasite 
plasma membranes. If the chemosensitisers act directly on a plasma 
efflux pump, it would indicate that this activity has not been stimulated. However, 
the target of chemosensitisers has not yet been identified in Jalciparum and 
these results would suggest either that target of chemosensitiser is absent from 
the parasite plasma membrane or their mode of action does not involve an A TP­
dependent mechanism. Moreover, a similar study conducted in our laboratory failed 
to show any effect of verapamil, progesterone and trifluoperazine on P. Jalciparum 
vacuolar ATPase activity (Adams, 1999). Nevertheless, it would be interesting to 
test of on the ATPase activity over a of 
concentrations, since it has been shown that drugs like trifluoperazine or verapamil 
have a biphasic effect on P-glycoprotein activity, producing a stimulation of 
activity a low concentrations, followed by inhibition at higher concentrations (Doige 
et at., Garrigos et 1993). 
Chloroquine accumulation in resistant P. Jalciparum parasites was observed to 
more sensitive to the inhibitor bafilomycin than its sensitive 
COlunterr>an:s which lead to the that a vacuolar proton pumping 
activity could be respo sible for ";;\..II",v\;;\..I chloroquine accumulation (Bray et al., 
1992a). However, chloroquine-sensitive and -resistant parasites were shown to 
display similar vacuolar ATPase in the presence of bafilomycin Al and thus failed 
to provide evidence for an weakened protori pump activity in purified food vacuoles 
from chloroquine-resistant Jalciparum (Adams, 1999). In contrast, study 
showed that plasma membranes isolated from chloroquine-sensitive P. Jalciparum 
were more sensitive to bafilomycin Al than their resistant counterparts. Bafilomycin 
Al (1 J.1.M) reduced the D 10 plasma membrane ATPase activity by 47%, while this 
inhibitor had no effect on Fac8 plasma membrane ATPase activity suggesting the 
presence of a V-type ATPase in D10 plasma membrane which is underexpressed or 
altered in plasma membrane of chloroquine-resistant Fac8. However, the 
60 

Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 3: Characterisation falciparum Plasma Membrane ATPase Activity 
difference observed between the ATPase activities of plasma membranes isolated 
from 0 and Fac8 in the presence of bafilomycin Al was not statistically 
significant (p=O.097) while N-ethylmaleimide (2mM) had no on 
the plasma membrane activity. results are consistent with the reported 
subcellular distribution of the V-type-W-ATPase B-subunit within the parasite, 
shown by indirect immunofluorescence to be located in both the plasma and 
vacuolar membrane (Karcz et al., 1994). It has been argued that plasma 
membrane V-type ATPase is the major mechanism accounting the 
(Saliba and Kirk, 1999). Although the genes encoding the A and B subunits the 
falcipantm proton pump have been sequenced, no mutations or overexpression of 
these genes which could explain chloroquine resistance has yet been observed 
(Karcz et al., 1993a; Karcz et ai, 1994). 
Sanchez et al. (1997) demonstrated that arniloride and its derivatives inhibit 
chloroquine uptake in infected erythrocytes. Further studies indicated that the 
of chloroquine-sensitive parasites was stimulated by chloroquine whereas 
chloroquine-resistant parasites was constitutively activated and therefore 
insensitive to further stimulation by chloroquine (Wunsh et al., 1998). 
D 1 0 plasma membrane ATPase activity was considerably stimulated by arniloride 
and its derivatives tested in this study while resistant counterpart was shown to be 
stimulated to a lesser extend by the inhibitors amiloride, and EIP A at a 
concentration of lOOj.lM. Interestingly, a study conducted in our laboratory indicated 
that EIP A at concentration was able to stimulate chloroquine accumulation in 
and DIO erythrocytes. the specificity of amiloride and 
derivatives can be challenged since has been shown to inhibit the 
generation of a W gradient by a V-type in the plasma membrane of 
insect (Wieczorek, et 1991). Moreover, Saliba and (1999) argued that 
arniloride and effects on are not related to an effect on an but rather 
consistent with arniloride acting as an inhibitor of the V-type W -ATPase. This 
proposal was supported by the finding that the of and bafilomycin 
Al was not additive. Furthermore, Bray et al. (1999) argued that than effect 
arniloride its derivatives on chloroquine uptake is due to chloroquine binding 
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interactions within the parasite. The ability to stimulate the plasma membrane 
ATPase activity found in this study indicates that amiloride and its derivatives have 
properties other than that of a NHE inhibitor. Since DI0 plasma membrane ATPase 
activity was stimulated to a greater extent than its resistant counterpart, the ATPase 
composition of these 2 membranes appeared to be different. 
Mefloquine, quinine and artemisinin were reported to inhibit the vacuolar ATPase 
activity (Choi et Mego, 1988). In this study, we found that mefloquine (ImM) and 
quinine (0.1mM) inhibit the ATPase activity of membranes isolated from the 
chloroquine-resistant strain Fac8 by 40 and 29%, respectively, while these 
antimalarials had little effect on the ATPase activity of membrane purified from the 
chloroquine-sensitive strain DIO. The differential sensitivity of the ATPase from 
plasma membranes isolated from chloroquine-sensitive and -resistant strains 
towards these antimalarials suggests the possible presence of a component in the 
parasite plasma membrane involved in the mechanism of mefloquine-resistance. In 
contrast, artemisinin had no or little effect on the ATPase activity of purified plasma 
membranes from the chloroquine-resistant and -sensitive strain, respectively. This 
differential effect of metloquine and quinine, in one hand, and artemisinin, on the 
other hand on the plasma membrane ATPase activity indicates that these 
antimalarials might not share the same target in the plasma membrane. 
3.4 Conclusion 
Optimal conditions for P. jalciparum plasma membrane ATPase activity were 
determined using the D 10 strain. Plasma membranes isolated from chloroquine­
sensitive parasites appeared to display a lower ATPase activity than their resistant 
counterparts. This chapter support the view of an ATPase activity associated with a 
V -type ATPase in the plasma membranes isolated from the chloroquine-sensitive 
strain of P. jalciparum, as well as differential activities for metloquine and quinine 
compared to artemisinin. 
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CHAPTER 4 
Characterisation of chloroquine accumulation in isolated 

Plasmodium /alciparum plasma membrane vesicles 

4.1 Introduction 
The mechanism responsible chloroquine-resistance is still controversial. Drug 
transport is believed to be of crucial importance understanding the mechanism of 
chloroquine resistance as it is clear that chloroquine-resistant parasites accumulate 
chloroquine than resistant parasites (Bray and Ward, 1998). This lack of 
chloroquine accumulation was initially attributed to an efflux mechanism but latter 
studies rather the presence an uptake mechanism (Ridley, 
Chloroquine accumulates into parasitised erythrocytes several hundred folds when 
compared to uninfected erythrocytes (Geary et al., 1986). chloroquine is 
concentrated in the vacuoles of falciparum 600- to 800-fold more than can 
be accounted by its properties as a diprotic weak (Krogstad, 
1987b). The role of the parasite plasma membrane in accumulating chloroquine in 
parasitized erythrocyte is still unknown. Chloroquine accumulation studies in 
plasmodial food vacuoles failed to fully explain the mechanism of chloroquine 
and could suggest a possible involvement the parasite plasma 
membrane in chloroquine mechanism. Therefore to obtain purified """''''"".1'"" 
plasma membranes is of particular to study its role in the mechanism of 
chloroquine accumulation. 
chapter will determine the chloroquine l:,:>rI1:11'",,'"<, all the strains used in this 
study. Chloroquine accumulation in infected-erythrocytes and in plasma membranes 
isolated from chloroquine-sensitive and -resistant parasites will be characterised. 
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The specificity of efIJ-chloroquine accumulation in plasma membranes win be 
examined using an excess cold chloroquine. Chloroquine accumulation in 
parasitised erythrocytes has been shown to energy-dependent saturable (Fitch 
et aI., 1974; Chou et 1980). Therefore, ATP-dependence of chloroquine 
accumulation in plasma membranes be investigated to determine whether an 
ATP-driven drug transport occurs at the plasma membrane level. further 
characterise chloroquine accumulation capabilities plasma the 
of external chloroquine concentration on chloroquine accumulation in 
membranes isolated from 2 chloroquine-sensitive and 3 chloroquine-resistant 
Jalciparum strains be examined. 
Observations reduced chloroquine accumulation in chloroquine-resistant 
Jalciparum and the ability of verapamil and a number of other unrelated agents to 
reverse chloroquine prompted mechanistic comparison of chloroquine 
resistance in the parasite with multi drug resistance in mammalian cancer cell lines 
(Martin et aI., 1987). The IS to function as an ATP-driven 
drug exporter in the plasma membrane cancer cells and chemosensitisers are 
thought to either directly to P-pg or act as inhibitors of drug transport via 
indirect biophysical effects on plasma membrane fluidity (Wadkins and Houghton, 
1993). Despite compelling evidence common reversal mechanism 
2 cell this model by 
al., 1997; Bray et al., To determine whether chemosensitisers act at the 
plasma membrane level, their effect on chloroquine accumulation will examined. 
was identified on the P. Jalciparum plasma and vacuolar membrane as a 
potential component of chloroquine uptake and its resistance mechanism (Cowman 
et ,1991). such as Pgh 1, are characterised by the presence a 
phosphorylated intermediate and can inhibited vanadate, a transition state 
analogue phosphate. Oligomycin, an inhibitor the mitochondrial membrane 
phosphoryl has been shown to inhibit P-gp 
et 
mediated drug transport (Hollo et , 1994; Homolya et aI., 1 It 
therefore interesting to study the of ATPase inhibitors on the 
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accumulation capabilities of isolated plasma membranes in order to establish 
role played by P-type and V-type ATPases in chloroquine accumulation. 
4.2 Results 
4.2.1 Chloroquine susceptibility of Plasmodium Jalciparum strains 
Susceptibility of the parasites to chloroquine was evaluated the 
described by Maider et al (1 993b). Chloroquine dose-response relationships of the 6 
strains used in this study were determined a 48h-drug exposure using the 
parasite lactate dehydrogenase activity as an indicator of parasite viability. The 
recommended chloroquine plasma concentration of 30 Ilg/l required for the 
treatment of susceptible P. jalciparum (Wemsdorfer and McGregor, 1988, Katzung, 
1 was taken as threshold for chloroquine sensitivity. 10 and RSA3 were 
found to be chloroquine-sensitive with values of .53 and 52.46± 
17.01 respectively. Fac8, RSAll, RSA15 and Kl were chloroquine­
with ICso values 157.50± 55.98, 20.79, 294.77± 31.86 and 
379.1O± 34.96nM (n=3), respectively (figure 12). 
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Figure 12: Chloroquine dose-response curves for the Plasmodium falciparum 
strains DlO, RSAJ, Fac8, RSA11, RSA15 and Kl. The range of chloroquine 
concentration was either 1.95 to 1000 nM or 3.90 to 2000nM. point represents 
the means of 3 separate experiments. Each experiment was performed in 
quadruplicate. Curves were fitted using the GrapbPad Prism version 2.01 software. 
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4.2.2 Chloroquine accumulation in erythrocytes parasitised with chloroquine­
resistant or -sensitive Plasmodium falciparum 
Chloroquine accumulation in parasitised erythrocytes was evaluated over a 1 to 
500nM external chloroquine concentration range (see section 7.8). The chloroquine­
sensitive strain D 1 0 accumulated more chloroquine than the chloroquine-resistant 
strains Fac8 and KI at all the concentrations tested (Figure 13). 
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----.- 010 0::: 
a.. 40000 
-- Fac8CD 
o 
..... 
--- K1
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:J 
C" 
o 
o 
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u 
~ 
O~=---~----~------~----~-----.----~ 
o 100 200 300 400 500 600 
Chloroq uine concentration (n M) 
Figure 13: Chloroquine accumulation in erythrocytes parasitised with the 
Plasmodium Jalciparum strains DIO, Fac8 and KI over a range of external 
chloroquine concentrations from 1 to 500nM. Chloroquine accumulation in 
unparasitised erythrocytes was subtracted. Chloroquine accumulation is expressed as 
fmollI06 parasitised erythrocytes. Error bars represent standard deviations from 
means of3 separate experiments, each performed in duplicate. 
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Figure 14: Chloroquine accumulation in Plasmodium jalciparum plasma 
membranes isolated from the Plasmodium jalciparum strains D10, RSAJ , RSAll , 
Fac8 and Kl in the presence or absence of 2mM ATP. Chloroquine accumulation is 
expressed as finoVmg protein/h. Error bars represent standard deviations from 
means of 3 separate experiments, each performed in duplicate_ 
4.2.5 Effect of external chloroquine concentration on chloroquine accumulation 
in parasite plasma membranes isolated from chloroquine-resistant and ­
sensitive strains of Plasmodium Jalciparum 
Chloroquine accumulation by parasite plasma membranes isolated from different 
strains of Plasmodium jalciparum exhibiting various degrees of chloroquine 
resistance was evaluated at 1, 100, 2S0 and SOOnM of external chloroquine 
concentrations in the presence of 2mM ATP. Parasite plasma membranes isolated 
from the chloroquine-sensitive strains D 1 0 and RSAJ accumulated significantly 
(p:S;O.OS) less chloroquine than the chloroquine-resistant strains RSAl1 , Fac8 and 
Kl at all the concentrations tested (Figure IS). 
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Figure 15: Chloroquine accumulation by parasite plasma membranes isolated from 
the Plasmodium Jalciparum strains DIO, RSA3, RSAII, Fac8 and KI at external 
chloroquine concentrations of I, 100, 250 and 500nM. Chloroquine accumulation is 
expressed as fmol/mg protein/h. Error bars represent standard deviations from 
means of 3 separate experiments, each performed in duplicate. 
4.2.6 Effect of chemosensitisers on chloroquine accumulation in Plasmodium 
Jalciparum plasma membranes 
Verapamil (I 0J,lM), trifluoperazine (I 0J,lM) and progesterone (100J,lM) had little or 
no significant effect on the accumulation of eH]-chloroquine by plasma membrane 
purified from the P. falciparum strain Fac8 (Figure 16) with p values of 0.2963, 
0.0455 and 0.2878, respectively. Ethanol (0.25%) used to solubilise progesterone 
had no effect on chloroquine accumulation by the membranes (data not shown). 
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Figure 16: Effect of the chemosensitisers verapamil(IOIlM), trifluoperazine (IO!lM) 
and progesterone (lOOJ..l.M) on the accumulation of eH]-chloroquine by plasma 
membrane purified from the P. falciparum strain Fac8. Chemosensitisers were 
added to the assay IS-min. prior to the addition of eH]-chloroquine. Values are 
expressed as percentages of controls without drugs and error bars represent standard 
deviations from means of 3 separate experiments, each performed in duplicate. 
4.2.7 Effect of ATPase inhibitors on chloroquine accumulation in Plasmodium 
falciparum plasma membranes 
The absence of ATP-dependence for chloroquine accumulation into any of the 
isolated membrane vesicles tested suggested that the membrane ATPases were not 
involved in the uptake process. In order to confirm this, chloroquine uptake was 
measured in the presence of a number of ATPase inhibitors. Surprisingly, several 
inhibitors were found to reduce chloroquine uptake in the P. falciparum plasma 
membrane vesicles. The V-type ATPase inhibitors N-ethylmaleirnide (NEM) (2mM) 
and bafilomycin Al (1!lM) reduced chloroquine accumulation in D 10 plasma 
membranes by 57.3% and 61.3%, respectively. Ouabain (ImM), a classic inhibitor 
of the mammalian Na+IK+-ATPase, and an inhibitor of cation transport (Dawson, 
1984) inhibited chloroquine accumulation by 53 .2% while oligomycin (10J..l.g/ml) 
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decreased chloroquine accumulation by 64.3%. In contrast, vanadate (100~M) did 
not affect chloroquine accumulation in 010 plasma membranes (figure 17). 
The effect of most of the ATPase inhibitors tested, namely oligomycin, ouabain 
bafilomycin Al and NEM on chloroquine accumulation in plasma membranes 
isolated from the P. Jalciparum strain FacS was found to be statistically significant 
with p values of 0.0014, 0.0065, 0.0023 and 0.0095, respectively. Only vanadate 
was shown to not have a statistically significant effect on chloroquine accumulation 
in FacS plasma membranes (p=0.4S70) . The presence of dimethylsulfoxide 
(DMSO), used to solubilise ouabain, oligomycin and bafilomycin Al at a final 
concentration of 0.5, 0.2 and 0.1 % respectively, had no effect on the accumulation 
of chloroquine in purified parasite plasma membranes (data not shown). 
150~--------------------------------------------------~ 
O~~======~~~ 
Oligomycin Ouabain Vanadate Bafilomycin A 1 
Figure 17: Effect of the ATPase inhibitors vanadate (0 . 1 mM), oligomycin 
(50~glrn1), ouabain (lmM), bafilomycin Al (l~, and N-ethylmaleimide (NEM) 
(2mM) on the accumulation of eH]-chioroquine by plasma membrane purified from 
the P. Jalciparum strain DIO. ATPase inhibitors were added to the assay IS-min. 
prior to the addition of elIJ-chioroquine. Values are expressed as percentages of 
controls without drugs and error bars represent standard deviations from means of 3 
separate experiments, each performed in duplicate. 
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3.3 Discussion 
Of the P. Jalciparum strains used, D 1 0 and RSA3 had IC50 values consistent with 
chloroquine-sensitive strains, while Fac8, RSAll, RSAI5 and KI had IC50 values 
consistent with chloroquine-resistant strains. The strains exhibited a 13-fold 
difference in chloroquine sensitivity, which made them suitable for an investigation 
of chloroquine resistance. RSAI5 was discarded in this study, as its IC50 is similar to 
that ofRSAII. 
Chloroquine accumulation patterns of erythrocytes infected with DIO, Fac8 and KI 
trophozoites exposed to increasing concentration of external chloroqui e were found 
to correlate with published data (Fitch, 1970; Bray et al., 1 992a; Bray and Ward, 
1993). These results confirmed the observation that chloroquine-sensitive parasites 
accumulate chloroquine at a higher level than the chloroquine-resistant parasites. 
The significant decline in chloroquine accumulation between infected erythrocytes 
and their purified vacuoles (Saliba et al., 1998) indicates a possible role for the 
plasma membranes in accumulating chloroquine. 
CH]-Chloroquine accumulation by parasite plasma membrane vesicles isolated from 
the Plasmodium Jalciparum strain D 10 was demonstrated to be specific as it was 
effectively inhibited by excess unlabelled chloroquine. Chloroquine accumulating 
capabilities of plasma membranes isolated from P. Jalciparum strains exhibiting 
various degree of chloroquine sensitivity was evaluated at external chloroquine 
concentrations of 1, 100, 250 and 500nM. Herwaldt et al. (1990) found similar 
chloroquine accumulation in membrane preparation from either a chloroquine­
sensitive or -resistant parasites. In contrast, this study showed different chloroquine 
accumulating capabilities of membranes isolated from different strains. Parasite 
plasma membranes isolated from D 1 0 and RSA3 accumulated significantly less 
chloroquine than those isolated from Fac8, KI and RSAII at all the concentrations 
tested. These results are difficult to interpret since the vesicles isolated from CQR 
parasites would have been expected to accumulate less chloroquine than their 
sensitive counterparts. Nevertheless, it is interesting to notice that the degree of 
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chloroquine accumulation appears to correlate with the level of ATPase activity 
measured in plasma membranes isolated from the various strains tested (see section 
3.2.6). An explanation could be that these vesicles became leaky after saponin 
treatment. However, the fact that the trophozoites do not concentrate the dye trypan 
blue indicates that the integrity of the plasma membranes has been preserved. 
Another explanation for these find ings could be that an ATPase is involved, either 
directly or indirectly in the mechanism of chloroquine accumulation into these 
vesicles. However, while Herwaldt et ai. (1990) found an ATP-dependent 
chloroquine accumulation in membrane preparations from P. falciparum infected 
erythrocytes, this study failed to show an ATP-dependent mechanism of chloroquine 
accumulation in the purified plasma membranes. Chloroquine accumulation in 
plasma membranes was similar in presence or in absence of ATP. Increased 
permeability to chloroquine or W in plasma membrane vesicles isolated from the 
CQS strains could explain the difference in the level of chloroquine accumulation 
observed. Increased permeability to W ions could lead to lower pH in CQR vesicles, 
resulting to increased chloroquine accumulation. However, it is unlikely that the 
vesicles are able to maintain a transmembrane pH gradient in the absence of ATP . 
Another likely explanation could be that the vesicles are not primarily right-side-out 
but, instead, inside-out in which case the difference in chloroquine accumulation 
observed between the membranes isolated from the chloroquine-sensitive and ­
resistant parasites could be attributed to an active pumping of chloroquine. 
However, the finding that chloroquine accumulation is independent of ATP would 
argue against a drug-pumping phenomenon and would suggests that the 
accumulation maybe a consequence of trapping of free chloroquine within the 
vesicles or binding of the chloroquine to a component of the membranes rather than 
transport. Considering the significant difference in chloroquine accumulation at all 
the concentrations tested of Plasmodium falciparum plasma membranes isolated 
from DI0 and Fac8, these 2 strains were chosen to further characterise their 
chloroquine accumulation capabilities in this study. 
Vanadate has been previously shown to be a potent inhibitor of Pgp ATPase activity 
(Shapiro and Ling, 1994; Urbatsch et ai., 1994) and can inhibit Pgp mediated 
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transport in membrane vesicles (Horio et al., 1988). In this study, vanadate did not 
affect chloroquine accumulation in D10 plasma membranes, suggesting that a P-type 
ATPase is not involved in the mechanism of chloroquine accumulation at the plasma 
membrane level. Herwaldt et al. (1990) also failed to show inhibition of chloroquine 
accumulation by vanadate in membrane preparations from P. falciparum infected 
erythrocytes. Moreover, chloroquine accumulation was reduced in the presence of 
oligomycin and NEM. Similarly this study found an inhibitory effect of these two 
ATPase inhibitors on plasma membrane chloroquine accumulation. The ATPase for 
chloroquine accumulation is similar to the mammalian vacuolar ATPase in its 
sensitivity to the V-ATPase inhibitors, NEM and bafilomycin AI. In addition, 
oligomycin and ouabain inhibited chloroquine accumulation in the plasma 
membranes. However as chloroquine accumulation was not dependent on the 
presence of ATP, one has to strongly mention the possibility of a non-specific effect 
of these inhibitors. It is difficult to reconciliate the inhibitory effect of ouabain with 
the absence ofa Na+fK+-ATPase. 
Verapamil and other unrelated compound has been shown to reverse chloroquine 
resistance by increasing chloroquine accumulation in parasitised erythrocytes 
(Martin et al., 1987; Krogstad et al., 1987a; Bray et aI., 1994). None of the 
chemosensitisers tested in this study, namely verapamil, trifluoperazine and 
progesterone had an effect on chloroquine accumulation in plasma membranes. This 
is consistent with the results obtained by Herwaldt et al. (1990) indicating that the 
drug tested (verapamil, vinblastine, desipramine and dialtiazem) inhibited 
chloroquine accumulation from resistant parasites only partially. Since these 
chemosensitisers are known reversers of chloroquine resistance, these results 
suggest that resistance reversal does not occur at the plasma membrane level. 
4.4 Conclusion 
This chapter determined the chloroquine sensitivity of the various P. falciparum 
strains used in this study and confirmed that parasitised erythrocytes isolated from 
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chloroquine-sensitive parasites accumulate more chloroquine than their resistant 
counterpart. The specificity of chloroquine accumulation by parasite plasma 
membrane was demonstrated and the chloroquine accumulation profile of plasma 
membranes isolated from chloroquine-resistant and -sensitive parasites was 
determined over several external chloroquine concentrations. Plasma membranes 
isolated from CQS parasites were found to accumulate less chloroquine than those 
isolated from CQR parasites. The observation that the degree of chloroquine 
accumulation correlates with the level of ATPase activity measured from various 
strains of P. falciparum lead us to the proposal that the parasite plasma membrane 
might play a role in determining the global level of chloroquine accumulation and 
hence chloroquine-resistance. However, the effect of ATPase inhibitors on 
chloroquine accumulation was inconclusive since chloroquine accumulation was 
found to be ATP-independent, suggesting that the measured accumulation might be 
due to binding rather than transport. This study failed to provide evidence that the 
chemosensitisers act at the plasma membrane level. 
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CHAPTERS 
Role of P-Glycoprotein Homologue 1 in Chloroquine 
accunlulation by Plasmodiumfalciparum plasma menlbrane 
5.1 Introduction 
Even though it has been extensively investigated, the role of Pghl in the mechanism 
of chloroquine resistance has not yet been elucidated. Chloroquine resistance shows 
similarities with multidrug resistance seen in mammalian tumor cells, since 
resistance can be reversed in vitro by verapamil and other unrelated compounds 
(Martin et ai., 1987). Multidrug resistant tumor cells are able to expel a large range 
of chemically distinct anti-tumor drugs (Skovsgaard, 1978). The multidrug 
resistance phenotype is believed to result from the overexpression of an ATP­
dependent drug exporter (Riordan et ai., 1985) and can be inhibited by several drugs 
including the calcium channel blockers (Tsuruo et al., 1984). A 170-kDa protein 
located on the plasma membrane has been identified as a likely candidate accounting 
for the phenomenon of multidrug resistance (Endicott and Ling, 1989). This P­
glycoprotein can be photoaffinity labelled by both drugs (Safa, 1992; Cornwell et 
ai., 1986) and ATP (Cornwell et ai., 1987b; Georges et ai., 1991). 
Plasmodium Jalciparum has 2 genes (pfmdrl and pfmdr2) that are homologous to 
the mdr genes in mammals (Foote et al., 1989; Wilson et ai., 1989). Of these 2 
genes, pfmdr1 has been found to be amplified in some chloroquine-resistant isolates 
of Plasmodium Jalciparum (Foote et ai., 1989). The pfmdr1 product, Pgh 1 is mainly 
localised on the membrane of the plasmodial digestive vacuole (Cowman et ai., 
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1991). Pgh1 contain 2 homologous ATP-binding cassette regions and has been 
shown to bind nucleotides by photoaffinity labelling (Karcz et al., 1993b), which is 
consistent with a role in drug transport. However, Further studies indicated that the 
level of chloroquine resistance in a number of field isolates did not correlate with the 
level of Pgh1 expression (Cowman et aI., 1994). It has then been suggested that 
several alleles of pfmdrl are closely linked to chloroquine resistance (Foote et aI., 
1989). In contrast, another study demonstrated that chloroquine resistance 
segregated independently of the pfmdr 1 and pfmdr2 genes in a genetic cross between 
a chloroquine-sensitive and a chloroquine-resistant strain (Wellems et al., 1990, 
1991). Using a heterologous expression system for pfmdrl gene to express Pgh1 in 
CHO cells, Van Es et al. (1994a) found that wild-type Pgh1 could mediate 
chloroquine accumulation while chloroquine-resistant associated mutated forms 
could not. However, chloroquine failed to photoaffinity label Pgh1 (Foley et al., 
1994). In view of these conflicting data, no consistent mol cular explanation which 
could account for a role ofPgh 1 in chloroquine-resistance has yet been found. 
The results presented in chapter 3 showed elevated ATPase activities in plasma 
membranes isolated from the CQR strains compared to the CQS strains. Although 
overall levels of Pgh 1 protein in the whole parasites have not been correlated with 
the chloroquine resistance phenotype, it is possible that Pgh 1 protein IS 
overexpressed in the plasma membrane of CQR parasites. This chapter aim to 
investigate this hypothesis. For this purpose, Pgh1 was identified in plasma 
membranes isolated from CQR and CQS strains ofP. jalciparum and the subcellular 
localisation of Pghl in infected-erythrocytes was examined. The effect of anti-Pgh1 
antibodies on chloroquine accumulation was also investigated. 
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5.2 Results 
5.2.1. Preparation of anti-Pghl antibodies 
5.2.1.1. Restriction enzymatic digestion of the pGEX vectors 
Plasmids pGEX-3X encoding for GST-Pghl fusion proteins (donated by Dr. A.F. 
Cowman from the Walter and Eliza Hall Institute of Medical Research, Melbourne, 
Australia) were transformed into E. coli. The presence of the correct recombinant 
was confirmed by restriction digestion using Hinc II, Hind III and Pst I digestions 
and gel analysis (plate 10 and 11). 
PGEX-5'-pfmdrl PGEX-3'-pfmdr1 
21.2 
5.1 5.45 kb 
5.27 kb 
2 3 4 5 6 7 8 9 10 
Uncut Pstl HindIli Pst! HindIII Pst! HindIII Pstl HindIli 
1 "i 
2.0 
Plate 10: Agarose gel electrophoresis ofpGEX-5'-pjmdrl and pGEX-3'-pjmdrl 
digested with Pst! and HindIII. Lane 1 contains DNA markers with approximate size 
expressed in kb. Lane 2 contains pGEX-5'-pjmdrl uncut. Lane 3 and 4 contain of 
pGEX-5' -pjmdr 1 digested with Pst! and HindlII, respectively. Lane 5, 7 and 9 
contain pGEX-3'-pjmdrl digested with PstI while pGEX-3'-pjmdrl is to be found 
lane 6, 8 and 10. 
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The pGEX-3X vector presents 1 restriction site for Pst 1 at position 1905, 3 
restriction sites for Hinc II at positions 184, 1605 and 4157 and none for Hind III. 
One restriction site for Hind III is to be found within the 3' -pfmdrJ insert at position 
4428 (figure 18). Therefore, the predicted restriction pattern for pGEX-3' -pfmdrJ is 
a single band of 5459 bp for Pst I or Hind III digestions and 3 DNA bands of 979, 
1928 and 2552 bp for Hinc II digestion. Similarly, pGEX-5'-pfmdrJ digested with 
Pst I should present one single band of 5267pb, 3 DNA bands of 979, 1736 and 2552 
pb for Hinc II digestion while this plasmid should stay uncut with Hind III. 
Electrophoresis of the digested plasmids on 1 % agarose gels showed the predicted 
fragments (plate 10 and 11). 
2.0 
1.6 
1.3 
0.98 
1 
pGEX-5'­
pfmdrl 
2 3 4 
pGEX-3'­
pfmdrl 
5 6 
2.55 
1 (n 
1.74 
0.98 
Plate 11 : Agarose gel electrophoresis ofpGEX-5'-pfmdrJ (lane3) and pGEX-3 ' ­
pfmdrJ (lane4, 5,6) digested with HincH. Lane 1 contains DNA markers with 
approximate size expressed in kb. Lane 2 contains pGEX-5' -pfindr 1 uncut. 
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GST ~Insert 
HincH (l605b) 
Pst! (l905bp) ~ 
---..... 
-""'IIIIIII...r-;-~ Insert 
IHindIIl 
HincIl (184pb) 
HincH (l605b) 
HincH (4157bp) 
Pst! (l905bp) 
A B 
Figure 18: restriction map ofpGEX-3X vector containing the 315 bp 5'-pfmdrl (A) 
or the 507 bp 3'-pfmdrl (B) insert. 
5.2.1.2. Sequencing of the Pfmdrl inserts of the pGEX-3X vector 
The sequence of pfmdrl inserts within the plasmids pGEX-3'-pfmdrl and pGEX­
5'pfmdrl were confirmed by sequencing (see section 7.12.5). Figure 19 shows the 
5'-DNA sequence of the 2024-2339 pb pfmdrl gene fragment encoding for the N­
terminal-ATP binding site (Foote et al., 1989; Gene bank accession number 
M29154). One base mismatch was found at position 249; however, this mismatch, a 
G instead of an A, does not alter the amino acid sequence. 
Similarly, the sequence of the 4252-4758 pb pfmdr 1 gene fragment encoding for the 
C-terminal Pgh1 protein is represented figure 20 (Gene bank accession number 
M29154). 
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5' ccc cCG AAT TCT ATG ACA TCA AAT GAA TTA TTA GAA ATG AAA AAA 45 
PP N S M T S N ELL E M K K 
GAA TAT CAA ACT ATT AAA GAT TCT GAT GTT GTT GAT GTG TCC AAA 90 
E Y Q T I K D S D V V D V S K 
AAA GTA CTI ATA CAT GAT TIT GTA TCA TCA TTA CCA GAT AAA TAT 135 
K V L I H D F V S S L P D K Y 
GAT ACC TIA GT A GGT TCC AA T GCA TCC AAA TTA TCA GGT GGA CAA 180 
D T L V G S N ASK L S G G Q 
AAA CAA AGA ATA TCC ATT GCA AGA GCA ATI ATG AGA AAT CCT AAA225 
K Q R I S I A R A 1M R N P K 
ATI CTA A TI CIT GAT GAA GCT ACG TCT TCT TT A GAT AA T AAA TCT 270 
I L I L D EAT S S L D N K S 
GAG TAT TIA GTA CAA AAA ACA ATI AAT AAT TIG AAA GGA AAT GAA 315 
E Y LV Q K TIN N L KG N E 
AA T AGg gaa ttc atc gtg act gac tga 3' 342 
N R EFIVTD* 
Figure 19: Nucleotide sequence and deduced amino acid sequence of the insert of 
pGEX -5' -pfmdr 1 vector. At the 5'-end, 4 nucleotides (lower case) from the cloning 
vector encoding the amino acids PP are indicated. The 3'-end of the pfmdr1 insert 
ends with AG at position 320. The following nucleotides (lower case) are part of the 
multiple cloning site of the pGEX-3X vector (gene bank accession number U13852). 
The mismatch in pfmdr1 sequence is shaded. 
5' TCA ATA GTI AGT CAA GAACCC ATG TIA TIT AAT ATG TCC ATA TAT 45 
S I V S Q E PM L F N M SlY 
GAA AA T ATC AAA TIT GGA AGA GAA GAT GCA ACA TIG GAA GAT GTI 90 
EN I K F G RED AT LED V 
AAA CGT GTT AGT AAG TIT GCT GCT ATA GAT GAA TIT ATC GAA TCA 135 
K R V S K F A A IDE FIE S 
TIA CCA AAT AAA TAT GAT ACA AAT GTI GGA CCA TAT GGT AAA AGC 180 
LPN K Y D TN V G P Y G K S 
TIA TCA GGT GGA CAA AAA CAG AGA AT A GCT AT A GCT AGA GCA TIA 225 
L S G G Q K Q R I A I A R A L 
TIA AGA GAA CCT AAA ATA TIA TIA TTA GAT GAA GCA ACA TCA TCA 270 
L REP K ILL L DE AT S S 
CTI GAT TCC AAT TCT GAG AAA TIA ATI GAA AAA ACT ATT GTA GAT 315 
L D S N S E K LIE K T I V D 
ATI AAA GAT AAA GCT GAC AAA ACT ATI ATI ACT ATI GCC CAC AGA 360 
I K D K AD K T I I T I A H R 
ATI GCA TCT AT A AAA CGA TCA GAC AAA A TI GTG GT A TIT AA T AAC 405 
I A S I K R SDK I V V F N N 
CCT GAT CGA AA T GGA ACC TIT GTA CAG TCA CAT GGA ACA CAC GAT 450 
P DR N G T F V Q S H G T H D 
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GAA ITA ITA TCA GCA CAA GAT GGA ATA TAT AAA AAA TAT GTA AAA 495 
ELL S A Q D G I Y K K Y V K 
ITA GCT AAA 
L A K 
tga 
* 
507 
Figure 20: Nucleotide sequence and deduced amino acid sequence of the insert of 
pGEX -3' -pfmdrJ vector. 
5.2.1.3. Sodium Dodecyl Sulfate-Polyacrylamide gel electrophoresis of purified 
fusion protein 
The GST -fusion proteins were purified by affinity chromatography. The yield of 
recovery expressed by protein determination of the N-terminal ATP-GST fusion 
protein was 1.5-2.0 and 0.1-0Amg/l of bacterial culture, respectively. 
Purified fusion proteins were examined using SDS-PAGE along with bacterial 
extract after induction of the GST -fusion protein by IPTG. Purification of the 
proteins was shown by the presence of a band of molecular weight of 38kD and 45 
kD corresponding to the N-terminal-ATP-GST and the C-terminal-GST fusion 
protein, respectively (plate 12). However, approximately 60% of the N-terminal­
ATP-GST fusion protein was degraded during the purification steps. 
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1A 2 A 3A 4A 
Plate 12: SDS-PAGE of purified ATp··GST fusion protein (lane 4A) and C-tenrunal 
GST fusion protein (lane 4B) compared to the bacterial extract after induction of the 
N-tenrunal ATP-GST (lane3A) and C-tenrunus-GST (lane3B) expression. Lane 2A 
and 2B contain the bacterial extract of the transformed cells before induction. Lane 
1 A and 1 B contain protein markers with approximate molecular weight expressed in 
kDa. 
5.2.1.4. Recognition of Pghl in trophozoites by rabbit serum directed against 
the N-terminal A TP-binding site and the C-terminus of Pghl 
Western blots of K 1 trophozoites revealed with rabbit serum against Pgh 1 were 
performed to detenrune whether these antibodies recognised Pgh1 . 10lJ,g of purified 
K 1 trophozoite protein were electrophoresed, transferred on PVDF membranes, and 
probed with rabbit serum raised against the N-terrninal ATP-binding site or the C­
tenrunus of Pgh1, at a dilution of 1 : 1000. Rabbit pre-immune serum was included as 
a control. Visualisation was performed with goat anti-rabbit antibodies conjugated to 
horseradish peroxydase. For a detailed description of the method see section 7.15. 
84 

Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 5: Role ofPghl in chloroquine accumulation by plasma membranes 
Antibodies raised against the N-terminal ATP-binding and the C-terminus of 
did recognise a band of approximate molecular weight of 160kDa 
corresponding to Pghl protein. A lower band of 75kDa was also "et;,t'g!,,,,!~_~ by the 
antibodies raised against the N-terminal ATP-binding site. None of these bands was 
recognised by the pre-immune sera (plate 13). 
IA 
4---175kDa 
_ ... 75kDa 
IB 2A 
.......r---- 175kDa 
Plate 13: Purified trophozoites protein (1 0llg) were electrophoresed, transferred 
to PVDF membranes and probed with either the rabbit serum against the N­
ATP-binding (lane IB) or the C-terminus of Pghl (lane 2B), at a 
dilution 1: 1000. Pre-immune sera were included as a control IA and 2A). 
Recognised bands were a chemiluminescent Approximate 
molecular weights ofthe bands are indicated. 
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5.2.2 Identification of Pgh1 in parasite p1asma membranes iso1ated from 
Plasmodium Jaldparum 
Equal amount of protein (10~g) of Fac8 food vacuoles, DIO, RSAJ, KI, Fac8 and 
RSAII plasma membranes were electrophoresed, transferred onto nitrocellulose and 
probed with the anti-PghI antibodies raised against the C-terrninus fragment of the 
protein. In the lane containing Fac8 food vacuoles, a double band in the 70-75 kDa 
region was detected in addition to the major band at 175 kDa. In all lanes containing 
175 ~ 
0
-(D 
83 n::::
-~ 
'""! 
62 ~ (D
-.(JQ
:::r 
47 ....... ~ 
8 
32 ~ 
'---' 
1 2 3 4 5 6 

P1ate 14: Equal amount of protein (10~g) ofFac8 food vacuoles (lane 6), DIO (lane 
2), RSAJ (lane 1), KI (lane 3), Fac8 (lane 4) and RSAII (lane 5) plasma 
membranes were electrophoresed, transferred onto nitrocellulose and probed with 
the anti-PghI antibodies raised against the C-terminus fragment of the protein. 
Recognised band were detected using chemiluminescence. Approximate molecular 
weights expressed in kDa are indicated 
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plasma membranes proteins, a band of approximate molecular weight of 75 kDa was 
detected while no band was found at 175 kDa. The intensity of the 75 kDa band was 
similar for RSA3, Fac8 and RSAll plasma membranes proteins while DlO plasma 
membrane proteins produced the strongest signal and K1 plasma membranes 
protein, the weakest (Plate 14). These bands of lower molecular weight might result 
from breakdown products of Pgh 1. The very strong band in lane 6 confirms the 
reported high concentration of Pghl protein present in Fac8 food vacuoles (Plate 
14). 
5.2.3 Localisation and membrane recognition with anti-Pghl antibodies by 
immunoelectron microscopy 
The subcellular localisation of Pgh 1 was investigated usmg immunoelectron 
microscopy by labelling section of RSA 11 trophozoite-infected erythrocytes using 
antibodies against Pgh11-18 peptide prepared in our laboratory (see section 7.12.9) 
and 10nm gold particles. Briefly, infected-erythrocytes were fixed with 
glutaraldehyde/formaldehyde and embedded in LR White resin. Then, 1 J.lm-thick 
sections of the sample embedded in resin were put onto a copper grid and stained 
with uranyl acetate. The rabbit anti-Pgh 11-18 was added and then anti-rabbit 
antibodies labelled with 10nm gold particles. As a control, rabbit pre-immune serum 
was used. For a detailed description of the method see section 7.17. 
No binding of gold was observed using a rabbit pre-immune serum (plate 18). The 
black dots show that Pghl is distributed allover the trophozoites but there is no 
Pghl in the erythrocyte itself (plate 15). Labeling was weak over the parasite plasma 
membrane indicating a very low amount ofPghl present in this membrane (plate 15, 
16, 17). 
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Plate 15: Immunogold electron microscope localisation of Pghl in RSAII 
trophozoites infected-erythrocytes (Magnification x25,OOO). The antibody used was 
the anti-PghI 1-18 followed by anti-rabbit labelled with lOnm gold particles. 
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Plate 16: Immunogold electron microscope localisation of PghTI in RSAll 
trophozoites infected-erythrocytes (Magnification x40,OOO). The antibody used was 
the anti-Pgh 11-18 followed by anti-rabbit labelled with 10nm gold particles. 
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Plate 17: Immunogold electron microscope localisation of Pghl in RSAl1 
trophozoites infected-erythrocytes (Magnification x40,OOO). The antibody used was 
the anti-Pgh 11-18 followed by anti-rabbit labelled with 10nm gold particles. 
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, .' 
- , 
~: ,­
Plate 18 : Electron micrograph ofRSAl l trophozoite infected-erythrocytes 
immunogold labelled using rabbit pre-immune serum (control) (Magnification 
xIO,OOO). 
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5.2.4 Effect of anti-Pghl antibody on chloroquine accumulation in isolated 
Plasmodium Jalciparum plasma membranes 
Antibodies to 2 fragments of pjmdrl encoding for the N-terminus ATP-binding site 
and the C-tenninus of Pgh 1 diluted 1 :20 in vesicle buffer II were incubated with 
40j.lg protein of purified D 10 plasma membranes for 15 minutes prior to the addition 
of InM eH]-chloroquine (see methods section 7.9). Plasma membranes were also 
exposed to the rabbit pre-immune sera as a control. None of the antibodies tested 
had a significant effect on chloroquine accumulation by plasma membranes (Figure 
21) 
200~----------------------------------------------~ 
Pre-i.(Cter) Anti-pgh1(Cter) PrEH. (ATP) Anti-pgh1(ATP) 
Figure 21 : Effect of anti-Pghl antibodies raised against the C-tenninus and the N­
tenninal ATP-binding site on chloroquine accumulation by DI0 plasma membranes. 
As a control, chloroquine accumulation by D 1 0 plasma membranes in presence of 
the rabbit pre-immune sera was detennined. Chloroquine accumulation is expressed 
as finoVmg protein/h. Error bars represent standard deviations from means of 3 
separate experiments, each performed in duplicate. 
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5.3 Discussion 
5.3.1. Preparation of antibodies to 2 fragments of pfmdrl encoding for the N­
terminal ATP-binding site and the C-terminus of Pgh1 
Competent cells were transfonned with two plasmid expression vector constructs 
encoding for the N-terminal ATP-binding site and the C-terminus of Pghl. The 
presence of the correct recombinant was confinne<l by restriction digestion using 
HincH, HindU and PstI digestions and gel analysis as well as sequence analysis of 
the inserts. More than 50% of the N-terminal ATP-GST fusion protein was degraded 
during the purification steps. Using milder sonication conditions or adding protease 
inhibitors during the purification of the protein did not improve this yield. In 
contrast, the C-terminal-GST fusion protein did not show any degradation during its 
purification. However, the yield of recovery was very low, probably due to the 
expression of the protein as an inclusion body. Antibodies raised against these two 
fusion proteins were shown to recognise Pghl in trophozoites and food vacuoles in 
western blotting experiments, as well as a protein of approximate molecular weight 
of 75kDa. Western blot of the P. falcipantm plasma membrane failed to detect a 
band of 175kDa. The pfmdr1 gene product pghl is reported to have an approximate 
molecular weight of 175kDa. This suggests that either the band recognised by the 
antibodies in the serum is not pgh 1, or else in the presence of reducing agents the . 
protein degrades into a 75kDa protein. Using a chemiluminescent detection system, 
Van Es et al. (1994a) detected a band with an apparent weight of 75kDa in addition 
to the band at 160kDa in the mitochondrial-lysosomal fractions of CHO cells 
expressing pfmdrl. It is possible that under the condition of the experiment, Pghl 
present in the plasma membrane was degraded and that only the breakdown products 
were detected by western blot. However, it is likely that the 75kDa band detected in 
western blotting experiments is the result of a non-specific interaction with a 
parasite's protein. 
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5.3.2 Identification of Pghl in parasite plasma membranes isolated from 
Plasmodium falciparum 
The MDR phenotype in mammalian tumour cells is linked to the level of expression 
of a P-glycoprotein present in the plasma membranes of these cells (Endicott and 
Ling, 1989). By analogy, a similar mechanism was thought to occur in P. falciparum 
chloroquine-resistant strains. Cowman et al. (1991) demonstrated that Pghl protein 
ofP. falciparum is expressed at equivalent levels in trophozoites and food vacuoles 
isolated from chloroquine-sensitive and most of the chloroquin~resistant parasites. 
However, its expression in the plasma membrane of CQR and CQS strains of P. 
falciparum has not been shown. To determine if Pghl expression in the plasma 
membrane correlates with the resistant phenotype, we examined the level of 
expression in plasma membranes isolated from chloroquine-sensitive and -resistant 
parasites. This study failed to detect Pghl in plasma membranes isolated from CQR 
and CQS parasites and indicates that the level of Pgh 1 protein expression in the 
plasma membrane is not linked to the resistant phenotype. Interestingly, Cowman et 
al (1991) found that the CQR cloned line Fac8 displayed a higher expression of 
Pghl protein in trophozoites and food vacuoles than any other isolates they tested. 
Since the level of resistance of Fac8 was not greater than other isolates showing no 
increased Pgh 1 expression, it was argued that no direct correlation could be 
established between overexpression of Pghl protein and CQR phenotype. The data 
presented in this study suggest that Pgh1 is not present in the parasite plasma 
membrane or at such a low level that it could not be detected by western blot. Even 
if we consider that the 75kDa band detected is a breakdown product of Pghl, the 
intensity of this band was considerably low compared to the 175kDa band detected 
in the food vacuoles therefore invalidating any correlation between an 
overexpression of Pgh1 protein in the plasma membrane and the resistant phenotype. 
Since CQR phenotype has not been linked to either a mutation of pfmdrJ or an 
overexpression ofPghl protein, it is unlikely that Pgh1 acts as a direct transporter of 
chloroquine. Further evidence that chloroquine does not directly interact with Pghl 
came from photoaffinity studies showing that a photo affinity analogue of 
chloroquine failed to label Pgh1 (Foley et al., 1994). 
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5.3.3 Localisation and membrane recognition with anti-Pghl antibodies by 
immunoelectron microscopy 
Cowman et al. (1991) demonstrated by immunoelectron microscopy that Pghl 
protein is present mainly in the food vacuoles of mature parasites. In this study, 
examination of the subcellular localisation of Pghl in trophozoite infected­
erythrocytes by immunoelectron microscopy revealed that a very low amount of 
Pghl protein is present on the plasma membrane of the trophozoites. These results 
are not entirely consistent with Cowman et al. (1991) results showing that most of 
the Pghl protein is localised on the food vacuole. The data shown in this study 
indicates that Pgh 1 protein is distributed allover the trophozoites, most probably in 
the endoplasmic reticulum. The difference between the two experiments is that 
Cowman et al. (1991) used antibodies against the COOH-terminal 168 amino acids 
of the protein whereas the antibodies used in this study were raised against the N­
terminal 18 amino acids of Pghl. The fact that we detected the N-terminal region 
whereas Cowman et al. (1991) detected the C-terminal region could account for the 
difference observed. It is therefore proposed that Pgh 1 might be present in the 
membranous tubules and vesicles network of P. falciparum. However, it cannot be 
excluded that the antibodies raised against the N-terminal of Pghl interact non­
specifically with some of the parasite's proteins. 
5.3.4 EtTect of anti-Pghl antibody on chloroquine accumulation in isolated 
Plasmodium falciparum plasma membranes 
Antibodies directed at Pgp have been used to study drug accumulation properties of 
the protein. Several groups had demonstrated the ability of anti-Pgp to inhibit drug 
efflux in mammalian cancer cells (Hamada and Tsuruo, 1986~ Meyers et al., 1989; 
Mechetner and Robinson, 1992). In this study, none of the antibodies used, namely 
the antibodies directed at the N-terminal ATP-binding site and the C-terminus of 
Pghl, had an effect on chloroquine accumulation by the parasite plasma membranes 
confirming that Pghl is not directly involved in the mechanism of chloroquine 
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accumulation at the plasma membrane leveL' Another ~tudy performed in our 
laboratory showed that chloroquine accumulation in food vacuoles was not affected 
by the presence of anti-Pghl antibodies (Saliba, 1997). However, since the N­
terminal ATP binding site and the C-terminal, against which the antibodies are 
raised, would normally be exposed to the parasite cytosol, it is possible that the 
absence of effect on chloroquine accumulation in the parasite plasma membrane 
vesicles reflects the lack of accessibility of these antibodies to their bmding site on 
Pghl. 
5.4 Conclusion 
If Pghl play a role in chloroquine resistance, it is not linked to a differential 
expression of this protein in the plasma membrane. Subcellular localisation of Pghl 
failed to find evidence of its presence in the P. falciparum plasma membrane. The 
lack of inhibition of chloroquine accumulation by anti-Pghl antibodies and the 
absence of correlation between the level of Pghl expression in the plasma 
membrane and the chloroquine-resistant phenotype suggest that Pghl is not involved 
as a chloroquine transporter in the plasma membrane ofPlasmodium falciparum. 
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CHAPTER 6 
DISCUSSION AND CONCLUSION 
6.1. Discussion 
An early study from Aikawa (1972) demonstrated that chloroquine co centrates 
within P. jalciparom food vacuoles. Since then, it has been well established that CQS 
parasites accumulate more drug than their resistant counterparts (Ginsburg et al., 
1991; Bray et al., 1992a; Bray et al., 1994; Martiney et al., 1995; Sanchez et aI., 
1997; Bray et al., 1998; Wunsh et al., 1998). However, a study conducted by Saliba 
et al. (1998) demonstrated that chloroquine accumulates about 20-fold less in the 
isolated food vacuole of P. jalciparom than in the same number of infected­
erythrocytes. Since chloroquine has to cross several membranes to reach the food 
vacuoles where it concentrates, each of these could participate in the mechanism of 
drug accumulation. A facilitated transport or efllux mechanism within the parasite 
plasma membrane could therefore account for the decline in chloroquine 
accumulation observed between the infected erythrocytes and their food vacuoles. 
Furthermore, chloroquine accumulation has been shown to consist of a saturable and 
non-saturable component (Fitch et aI., 1970; 1974) and chloroquine sensitivity of the 
parasite has been correlated to the apparent affinity of the saturable uptake process 
(Raynes et al., 1999). Membranes other than that of the food vacuole could be 
implicated in either ofthese processes. 
To elucidate the possible role played by the P. jalciparum plasma membrane in the 
mechanism of chloroquine accumulation and resistance, a method was developed for 
the preparation ofparasite plasma membrane vesicles. One ofthe criteria for this 
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Figure 22: Schematic representation of various model describing chloroquine uptake 
and possible sites ofchloroquine resistance in the P. Jalciparum trophozoites. 
study was the obtention of the plasma membrane in the form of vesicles in order to 
study their drug transport capabilities. For the same reason, the vesicles recovered 
should be the right way around and not inside-out. Finally, another prime 
consideration was to ensure that these plasma membrane vesicles were intact and free 
of contaminating organelles and membranes. The method described in chapter II of 
this thesis meets these requirements and therefore allowed us to characterise the 
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ATPase activity and the drug transport properties of isolated P. Jdlciparum plasma 
membranes. 
Conditions were determined in chapter ill for optimum ATPase activity of P. 
Jalciparum plasma membranes. No linear relationship was observed between plasma 
membrane ATPase activities and chloroquine sensitivity ofP. Jalciparum. However, 
plasma membranes isolated from the CQS parasites were found to display aJower 
ATPase activity than their resistant counterparts. When the ATPase activity of the 
plasma membranes isolated from various strains of P. Jalciparum was compared to 
their chloroquine accumulation properties, it was striking to observe that they display 
a similar profile. This finding would suggest a possible link between the level of 
chloroquine uptake in these vesicles with the level of plasma membrane ATPase 
activity. However, the lack ofdependence ofchloroquine uptake on ATP complicates 
interpretation of this data. Chloroquine uptake in plasma membrane vesicles isolated 
from the CQR P. Jalciparum could result from (1) a decreased effiux of W due to a 
defective W-ATPase, (2) a NHE facilitating the transport of chloroquine, (3) a P­
type ATPase such as PghI acting either as a chloroquine transporter or a chloride 
channel, (4) binding of chloroquine to a component ofthe parasite plasma membrane. 
The plasma membrane ATPase activities of a chloroquine-sensitive and a -resistant 
P. Jalciparum were selectively inhibited to determine any correlations between P-type 
and V-type ATPase activities and either the chloroquine uptake capabilities or 
chloroquine sensitivity of a strain. 
Genes encoding the A and B subunits of a V-type W-ATPase have been identified in 
P. Jalciparum (Karcz et al., I993a; 1994) and chloroquine accumulation in resistant 
P. Jalciparum was found to be more sensitive to the V -type ATPase inhibitor 
bafilomycin Al (Bray et aI., I992a). However, a study conducted in our laboratory 
(Adams, 1999) showed that bafilomycin Al (1J.1M) and NEM (10J.1M) reduced the 
vacuolar ATPase activity of DlO and Fac8 by 50% and 38%, respectively. Similar 
results were obtained by Choi and Mego (1988) using concentrations of NEM and 
NBD-CI between O.5mM and 1mM. In this study, it was found that bafilomycin Al at 
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similar concentration inhibited DIO plasma membrane ATPase activity by 47% and 
had little effect on Fac8 plasma membrane ATPase activity, therefore indicating that 
the CQS strain DI0 have a higher level of plasma membrane V-type ATPase activity 
than the CQR strain Fac8. The CQR parasite would therefore be expected to display 
a higher intracellular pH than the CQS parasites. This is consistent with Wunsch et 
al. (1998) study demonstrating by in vivo pH measurements that CQR parasites have 
an elevated cytoplasmic pH compared to that of chloroquine-sensitive parasites. 
It was initially thought that the parasite maintains its cytosolic pH through a P-type 
ATPase similar to those that operate in the plasma membrane ofyeast and plant cells 
(Mikkelsen et al., 1982; 1986). This hypothesis has since been questioned and later 
studies suggested either that the parasites extrude W by means of a NIlE (Bosia et 
al., 1993) or a V-type W-ATPase (Saliba and Kirk, 1999). It is possible that 
chloroquine uptake observed in the plasma membrane is partially pH-driven via a W­
ATPase. This would be consistent with the presence of a V-type Ir-ATPase on DIO 
plasma membranes since chloroquine was taken up to a lesser extent into D 1 0 
vesicles compared to those from the resistant strain. It is also possible that the 
intracellular pH is maintained by a combination of proton pump activity and Pgh 1 
acting as a chloride channel. It would therefore be interesting to measure the 
intracellular pH of the vesicles in presence/absence of V-type and P-type ATPase 
inhibitors. 
Chloroquine (pKal 8.1 and pKa2 10.2) and its structural analogues mefloquine and 
quinine (pKa 8.6) and quinine (pKa 8.4) are weak bases driven to accumulate in 
acidic compartments by a pH gradient maintained by proton pump activity. The pKa 
values of chloroquine, mefloquine and quinine indicates that only a small fraction of 
the weak: base should be uncharged at a physiological pH of 7.4. In some cell 
systems, a small pH change is compensated for by a decline in proton leakage via the 
NHE (Nelson, 1991) or a V-type Ir-ATPase (Moreno et al., 1998). This study 
showed that mefloquine (lmM) and quinine (O.ImM) inhibited Fac8 plasma 
membranes ATPase activity by 39% and 29%, respectively, while artemisinin had no 
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effect. An explanation could be that the weak base antimalarials inhibited a W­
ATPase to compensate the pH increase due to the accumulation of the weak base in 
Fac8 plasma membrane vesicles. The pH change in D 1 0 pblsma membrane vesicles 
due to the weak base might be too small to induce inhibition of the W-ATPase since 
chloroquine has been shown to accumulate in these vesicles to a lesser extent. 
Chloroquine uptake in membrane preparations from P. Jalciparum was reduced by 
64% using oligomycin (10~g/ml) (Herwaldt et al., 1990) while vanadate (100J.1M) 
completely inhibited the ATPase activity of purified P-glycoprotein from Chinese 
hamster ovary cells (Urbatsch et al., 1994). Choi and Mego (1988) reduced the 
ATPase activity of P. Jalciparum vacuolar membranes by 15% using 100J,tM 
vanadate while oligomycin (2~g/ml) was completely ineffective. In this study, 
vanadate (0.1mM) inhibited by 41% and 28% the ATPase activity of purified plasma 
membranes from the strain DlO and Fac8, respectively. However, the specificity of 
vanadate can be questioned since it has been shown to inhibit non-P-type-membrane­
associated ATPases (prossnitz et al., 1989). Therefore, the inhibition observed in this 
study could be non-specific and possibly result from the inhibition of a V-type 
ATPase or another ATPase present in the plasma membrane of P. Jalciparum. To 
combine the effect of bafilomycin Al and vanadate on the plasma membrane activity 
would determine whether a P-type ATPase contribute in the effect observed with 
vanadate or result from a non-specific inhibition of a V-type ATPase. Interestingly, 
oligomycin (50J.lg/ml) inhibited Fac8 plasma membrane ATPase activity by 42% and 
had little effect on DlO, suggesting the presence of a P-type component in the Fac8 
plasma membrane. Furthermore, Herwaldt et al. (1990) showed that chloroquine 
uptake in vesicles prepared from P. Jalciparum was more sensitive to oligomycin 
than vanadate. These results would imply that Pgh 1 does not play a role in regulating 
chloroquine uptake in P. Jalciparum plasma membrane. 
Pghl, a P-glycoprotein homologue, has been identified on the plasma and vacuolar 
membrane of P. Jalciparum and was initially believed to transport chloroquine 
(Cowman et al., 1991). Based on the finding that chloroquine uptake in Chinese 
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hamster ovary cells transfected with pfindrl was inhibited by the proton pump 
inhibitor bafilomycin Al and the pH dissipator ammonium chloride, Van ES et al. 
(1994b) argued that Pghl acts as a chloride channel, enhancing chloroquine 
accumulation by modulating the P. jalciparum vacuolar pH rather than a specific 
carrier for chloroquine. In this study, the lack of correlation between Pghl expression 
and chloroquine sensitivity ofP. jalciparum together with the finding that antibodies 
directed against Pgh 1 failed to inhibit chloroquine uptake in the P. jalciparom plasma 
membrane vesicles indicates that Pghl is most probably not involved in the 
mechanism ofchloroquine accumulation in the parasite plasma membrane. 
Chloroquine resistance in P. jalciparum can be reversed by chemosensitisers such as 
verapamil (Martin et aI., 1987) and stimulation of the ATPase activity of P­
glycoprotein using chemosensitisers is well documented (Sharom et al., 1995; 
Urbatsch et aI., 1995; Garrigos et aI., 1993; Shapiro and Ling, 1995). In this study 
none of the chemosensitisers tested had an effect either on the ATPase activity or 
chloroquine uptake by purified P. jalciparom plasma membrane vesicles. It is 
therefore unlikely that the site of action of these chemosensitisers lies within the 
parasite plasma membrane. Since chemosensitisers which reverse multidrug resistance 
of tumor cells are also capable of modulating chloroquine resistance, these agents 
were proposed to function in a similar manner, and were therefore expected to 
stimulate a P-glycoprotein activity. However, verapamil (101J.M), progesterone 
(5IJ.glml) and trifluoperazine (101J.M) had no significant effect either on the vacuolar 
ATPase activity of P. jalciparum (Adams, 1999). It was also proposed that 
chemosensitisers increase the affinity of chloroquine binding for the haem molecule if 
accumulation is driven by this mechanism (Chou et al., 1980; Bray et al., 1998; 
1999). It is therefore more likely that these chemosensitisers act at sites other than 
the plasma membrane ofP. jalciparum. 
NHE has been identified in P. jalciparum (Bosia et aI., 1993) and amiloride and its 
derivatives have been shown to inhibit chloroquine uptake in infected erythrocytes 
(Sanchez et al., 1997). An increase in cytoplasmic sodium concentration stimulated 
102 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 6: Discussion and Conclusion 
by chloroquine was observed in CQS parasites. Since this effect was inhibited by 
EIPA, it was argued that NHE is implicated in the mechanism of chloroquine uptake 
and probably resistance in P. Jalciparum. However. whether NHE play a role in 
chloroquine uptake was questioned as the process was shown to not require sodium­
hydrogen exchange since EIP A competitively inhibited chloroquine binding to FPIX 
in erythrocyte ghosts while chloroquine uptake in P. Jalciparum was unaffected by 
removing sodium ions from the reaction buffer (Bray et al.• 1998; 1999). Moreover, 
based on the finding that the effect of amiloride and bafilomycin Al on pHi was not 
additive, Saliba and Kirk argued that these effects are not related to NHE but rather 
with amiloride acting as a V-type Ir-ATPase inhibitor. In this study, amiloride and its 
derivatives DMA and EIP A at a concentration of 1OO~ considerably stimulated 
DI0 plasma membrane ATPase activity while its resistant counterpart was stimulated 
to a lesser extent. These results would suggest that amiloride and its derivatives are 
capable of stimulating an ATPase activity located in the plasma membrane of P. 
Jalciparum which would indicate that the effect observed with these inhibitors are not 
related to an effect on NHE. 
6.2. Conclusion 
Despite efforts to eradicate malaria in the 1950s, this disease remains a major health 
problem in tropical and subtropical regions of the world. The emergence and the 
spread of drug resistance in the malarial parasite Plasmodium Jalciparum, especially 
resistance to chloroquine, has proved to be a major obstacle to control this disease. 
Compared to other drugs, such as the antifolate pyrimethamine, resistance to 
chloroquine has been relatively slow to develop. Two foci of chloroquine resistance 
initially emerged in Southeast Asia and South America in the 1960s, and resistance 
has since spread to nearly every country where' malaria is endemic. Resistance of 
Plasmodium Jalciparum to all the major antimalarials used is now widespread with 
the only exception ofthe artemisinin derivatives. Therefore, the need for the judicious 
use of alternative antimalarials as well as preventing drug-resistance to new drugs 
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from emerging has emphasised the importance of understanding the molecular 
mechanism involved in the development ofdrug resistance. 
This thesis has focused on the development of a P. falciparum plasma membrane 
isolation which constitutes a suitable model for examining the mechanism involved in 
the accumulation of chloroquine and its resistance. Many sites, such as the 
parasitised-erythrocyte membrane, the parasitophorous membrane, the parasite 
plasma membrane and the food vacuole membrane can influence chloroquine 
accumulation in the malaria parasite. To date, elucidation of the role of the plasma 
membrane in the mechanism of chloroquine resistance has been impeded by the 
presence of other membranes in the membrane preparations. Therefore to obtain 
parasite plasma membranes purified from Plasmodium falciparum is of particular 
interest to study the mechanism of chloroquine accumulation. The availability of 
purified Plasmodium falciparum plasma membrane will be of value not only in the 
understanding of drug transport in this organelle but also to investigate processes 
such as nutrient uptake/efHux, pH regulation and ion balance. 
Parasite plasma membranes were obtained by saponin lysis of the erythrocytes and 
disruption of the trophozoites by nitrogen decompression. Trophozoites were 
purified of erythrocyte membranes by immunoaffinity chromatography using anti­
erythrocyte antibodies while the purification of the plasma membranes from 
contaminants was achieved using a magnetic cell sorting system. Enzyme marker 
assays, gel electrophoresis and transmission electron microscopy demonstrated the 
purity of plasma membranes from contaminating membranes and organelles. 
Furthermore, the degradation of membrane proteins by the proteases was prevented 
by the use of protease inhibitors. DNAse I was as well included in the purification 
process. 
Chloroquine sensitivity of 6 strains of P. falciparum and chloroquine accumulating 
capabilities of erythrocytes parasitised with two resistant and one sensitive strain 
were confirmed. The ATPase activity displayed by P. falciparum plasma membrane 
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was found to be time-, ATP- and cation-dependent. Other nucleoside triphosphates 
were hydrolysed as efficiently as ATP, but not AMP. The divalent cation Mn2+ was 
shown to support the parasite plasma membrane ATPase activity while Ca2+ did not. 
This thesis also provides evidence of a V -type ATPase present in the P. falciparum 
plasma membrane ofthe chloroquine-sensitive strain DIO. 
eH]-chloroquine accumulation by parasite plasma membranes was demonstrated to 
be specific. Chloroquine accumulation capabilities of plasma membranes isolated 
from 5 strains of P. falciparum were evaluated over 4 external chloroquine 
concentrations. Plasma membranes isolated from two chloroquine-sensitive strains 
accumulated significantly less chloroquine than those isolated from two of the three 
chloroquine-resistant strains tested, at all the concentrations tested. These results 
were unexpected since it is well established that erythrocytes infected with CQS 
parasites accumulate chloroquine at a higher level than their resistant counterparts. 
The difference in the level of chloroquine accumulation observed between these 
membrane vesicles could result from a difference in permeability of plasm~ 
membranes isolated from the CQR and CQS strains or in a binding phenomenon to a 
component of the membranes. These results provide evidence for a possible role 
played by the plasma membrane in accumulating chloroquine in the parasite. 
Results presented in this thesis indicate that the parasite plasma membrane is not the 
site of reversal of chloroquine resistance by agents such as verapamil. It has been 
proposed that two distinct mechanisms for chloroquine resistance exist, one that is 
verapamil reversible and one that is not. Therefore, a verapamil insensitive site of 
chloroquine accumulation, the parasite plasma membrane, and a verapamil sensitive 
one, probably the food vacuole contributes to the global chloroquine accumulation in 
the parasite. 
Studies implicating Pghl in the mechanism of chloroquine resistance have been 
contradictory. Data presented in this study indicate that Pghl is not involved in the 
mechanism of chloroquine accumulation by the P. falciparum plasma membrane. 
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Subcellular localisation of Pghl indicated that this protein is seldom present in 
Plasmodium jalciparum plasma membrane and antibodies directed at Pghl failed to 
inhibit chloroquine accumulation in these membranes. Furthermore, no 
overexpression of Pgh 1 could be associated with chloroquine sensitivity of the 
plasmodium jalciparum strains tested. Therefore, Pghl does not appear to play a 
role in the mechanism of chloroquine resistance, at least at the plasma membrane 
level. 
In conclusion, a method for the isolation and purification of the P. jalciparum plasma 
membrane was developed. This thesis provides evidence for a verapamil-insensitive 
site of chloroquine accumulation in the plasma membrane and demonstrated that 
Pgh 1 is not involved in the mechanism of chloroquine resistance at the plasma 
membrane leveL Finally evidence that a V-type ATPase is present in the parasite 
plasma membrane was demonstrated. 
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CHAPTER 7 
METHODS 
7.1. Culture ofPlasmodium/alciparum 
The chloroquine sensitive cloned DlO (derived from FCQ-27 from Papua New 
Guinea) (Ekong et al., 1993) and the chloroquine resistant FAC8 (derived from the 
Brazilian cloned line ITG2F6) (Biggs et al., 1989) strains ofPlasmodium Jalciparum 
were provided by Dr A. Cowman, Walter and Elisa Hall Institute of Medical 
Research in Melbourne, Australia. The chloroquine sensitive South African isolates 
RSA3 (North Eastern Transvaal) and the chloroquine resistant RSAll and RSA15 
(Kwazulu Natal) were obtained from Dr J. Freese, Medical Research Council of 
South Africa in Durban. The chloroquine resistant cloned isolates Kl (Thailand) 
(Thaithong and Beale, 1981) were donated by C. Weiss, School of Hygiene and 
Tropical Medicine, London. 
Plasmodium Jalciparum strains were cultured essentially as described by Trager and 
Jensen (1976). Parasites were maintained in continuous culture at a 5% haematocrit 
in RPMI-1640 with glutamine (Sigma) supplemented with hypoxanthine (44mgll), 
HEPES (N-[2-hydroxyethyl]piperazine-N' -[2-ethansulphonic acid] (6g/1), glucose 
(4g1l), NaHC03 (2.1 gil), gentamycin (50mgll), and 10% A+ human serum (Western 
Province Blood transfusion Service and Haematology Department, Groote Schuur 
Hospital, Cape Town, South Africa). Parasites were grown in O-positive red cells, 
which has been washed twice with 10 volumes of culture medium without serum to 
remove the buffy coat. The culture medium was changed daily and the parasitemia 
was kept between 10-15 %. Parasite cultures were incubated at 37°C in dessicator 
cabinets under an atmosphere of93% nitrogen, 4% carbon dioxide, 3% oxygen. 
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Parasite proliferation was assessed by light microscopical examination of Giemsa 
stained thin smears of cultured blood. Thin smears were fixed with methanol and 
stained with 10% Giemsa (Sigma) in phosphate buffered saline (p.B.S.) for 10 
minutes at room temperature. The slides were washed with water, dried and viewed 
under a Leitz laborlux 12 microscope with a 100 x oil (1,250 centistokes) (Sigma) 
immersion objective. 
Synchronisation to ring forms was achieved by sorbitol treatment (Lambros and 
Vanderberg, 1979). Cultured parasites containing mainly ring stages parasites were 
suspended in 5 volumes 5% D-sorbitol (Sigma) for 10 min. The parasitised 
erythrocytes were centrifuged at 602g for 5 min and the supernatant discarded. The 
pellet was then resuspended in culture medium at 5% haematocrit and returned to 
the incubator. This culture contained only the rings and consisted of parasites in the 
trophozoite stage the following day. 
Parasites were cryostored in liquid nitrogen. To cryopreserve a culture, the 
parasitised erythrocytes in the ring stage with a parasitemia > 2% were centrifuged 
and the cells were resuspended in an equal volume of 28% glycerol in P.B. S. The 
suspension were frozen in 0.5ml aliquots and stored in a liquid nitrogen refrigerator. 
To retrieve a culture, parasites we e thawed at 37°C in a water bath and transferred 
to a lOml centrifuge tube. After addition of Iml3.5% NaCI, prewarmed to 37°C, the 
cells were centrifuged at 602g for 5 min. The supernatant was removed and replaced 
with 1 ml 3.5% NaCl. The suspension was again centrifuged and the supernatant 
removed. This washing step was repeated once. The resulting pellet was 
resuspended in 10ml culture medium supplemented with 100-200J..tl of washed blood 
and placed in culture. 
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7.2 Isolation and purification ofPlasmodium falciparum trophozoites 
7.2.1. Trophozoite isolation by sorbitol lysis 
Trophozoites were isolated mainly as described by Hoppe et al. (1992). IOml of 
culture was sedimented at 602g, for 5 min and resuspended in 3ml of an 8% (w/v) 
sorbitol-supplemented serum-free RPMI-1640 medium (Sigma). After incubation 
for 1 min the cells were sedimented by brief centrifugation, and rapidly suspended in 
1ml of serum-free culture medium by vortexing in order to lyse the infected­
erythrocytes and release the parasites. Immediately after lysis, the protease inhibitors 
aprotinin, leupeptin and phenylmethylsulfonylfluoride (pMSF, Boehringer 
Manrtheim) were added to final concentration of IOllglml, IOllglml and 0.1mM, 
respectively. Isolated trophozoites were further purified by immuno-affinity 
chromatography. 
7.2.2 Trophozoite isolation by saponin lysis 
Infected erythrocytes were washed twice in 10 volumes P.B.S. The pellet was 
suspended in 10 volumes of PBS containing 0.05 % (w/v) saponin in order to lyse 
the erythrocytes. It was then incubated for 2-3 min at room temperature and 
centrifuged at 1,500g for 10 min. The resulting pellet was washed twice in P.B.S. 
and resuspended in 5 volumes P.B.S. The protease inhibitors aprotinin, leupeptin 
and phenylmethylsulfonylfluoride (Boehringer Mannheim) were added to final 
concentration of IOllglml, 10 llglml and O.lmM, respectively. Isolated trophozoites 
were further purified by immuno-affinity chromatography. 
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7.2.3. Immuno-affinity purification oftropbozoites 
Unlysed erythrocytes and erythrocytes membranes contained in the trophozoite 
preparation were adsorbed onto the immuno-affinity column. Anti-human 
erythrocytes (polyvalent immunoglobulin (G,A,M) rabbit, Sigma) were diluted I : 
1000 in P.B.S. 5g of polystyrene beads (pierce) were incubated in 20ml of the above 
solution for 2 hours at room temperature with gentle agitation. The beads were 
washed in P.B.S. and further incubated for I hour with 20ml 1% bovine serum 
albumin. in P.B.S. The beads were washed again in P.B.S., incubated with the 
trophozoite preparation for 30 min, packed in a column (20ml propylene seringe) 
and eluted under gravity with 2 washes each in IOml P.B.S. The purified trophozoite 
were collected and centrifuged at I,500g for 10 min. 
7.3. Preparation ofP. jalciparum plasma membranes 
7.3.1. Parasite plasma membrane isolation by fixation to a ditbio-NBS support 
The cross-linking reaction was performed by incubating 20~1 glass beads 
arninopropyl (l0nM) (Sigma), 180,.11 trophozoites (0.1-0.5mg protein) and 10 ~l 
DSP (dithiobis succinimidyl propionate) (2mM) (pierce) for 30 min, 1 or 2 hours at 
4°C. Cross-linked beads were blocked for 15 min in Tris-HCI 1M pH 7.5. The beads 
were washed first in P.B.S., then twice in Vesicle buffer I (0.25M sucrose, ImM 
E.D.T.A., 10mM Tris-HCI pH 7.4). Vesicles were prepared by nitrogen cavitation 
according to the method ofLever et al. (1977). The trophozoites linked to the beads 
were resuspended in 500111 vesicle buffer I containing aprotinin, leupeptin and 
phenylmethylsulfonylfluoride (lO~glml, lO~glml and O.lmM, respectively) and 
equilibrated at 4 °C under nitrogen pressure at 800 psi for 30 min. The homogenate 
was then incubated for 5 min at 37°C with Dnase I (50~glml). The vesicles were 
washed twice in 0.25M sucrose, 10mM Tris-HCI pH 7.4. 
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7.3.2. Magnetic streptavidin purification of parasite plasma membrane 
The biotylination reaction was performed by incubating 2S0"d Imglml NHS-SS­
Biotin (sulfosuccinimidyl 2-[biotin-amido] ethyl-l,3-dithiopropionate) (pierce) with 
SOOJlI trophozoite (2 mg protein) for 30 min at room temperature. The resulting 
biotinylated trophozoites were washed once in P.B.S., then twice in Vesicle buffer I 
( 0.2SM sucrose, ImM E.D.T.A., lOmM Tris-HCI pH 7.4). Vesicles were prepared 
by nitrogen cavitation according to the method ofLever et al. (1977). The cells were 
resuspended in SOOJlI vesicle buffer I containing aprotinin, leupeptin and 
phenylmethylsulfonylfluoride (1 Ollglml, 10Jlglml and 0.1 mM, respectively) and 
equilibrated at 4 °C under nitrogen pressure at 800 psi for 30 min. The homogenate 
was then incubated for S min at 37 °C with Dnase I (SOJlglml). The biotinylated 
vesicles were incubated with 100/..11 of streptavidin immobilised on iron oxide 
(Sigma) previously washed with P.B.S., for IS min at room temperature and then 
separated using a high gradient magnetic separation column (Magnetic Cell Sorting, 
Myltenyi Biotec) placed in a strong magnetic field. The magnetically labelled 
vesicles were retained in the column and washed with 1 ml 0.2SM sucrose, 10mM 
Tris-HCl pH 7.4. The column was then removed and the magnetically retained 
vesicles were eluted with the same buffer. The separation of the magnetically 
labelled vesicles was also obtained by placing an eppendorf tube containing the 
solution in a strong magnetic field. The magnetic particles were bound to the side of 
the tube and washed with 1 ml in 0.2SM sucrose, lOmM Tris-HCI pH 7.4. 
7.4. Isolation of food vacuole 
Vacuoles were isolated using a protocol adapted from those of Goldberg et al. 
(1990) and Saliba et al. (1998). Sml of parasitized erythrocytes were washed twice 
in SOml P.B.S. and resupended in SOml P.B.S. containing 2Smg saponin. After a 
short incubation (2-3 min), the trophozoites were centrifuged at I,SOOg for 10 min. 
The pellet was washed twice with 1 ml ice-cold uptake buffer (2mM MgS04 , 
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100mM KCI, 10mM NaCI, 25mM HEPES, pH 7.4) and resuspended in 10 volumes 
ice-cold water, pH 4.5. This suspension was triturated 5 times through a 27 Yz -G 
needle. The food vacuole preparation was centrifuged in a microfuge at 13,500g for 
2 min and resuspended in 1ml uptake buffer. The suspension was then incubated for 
5 min at 37°C with 1OJ.i1 of 5mglml Dnase I, and centrifuged again. The resulting 
pellet was resuspended in 300J.i1 ice-cold uptake buffer and triturated 3 times 
through a 27 Yz -G needle. It was then added to 1.2ml ice-cold 42% Percoll™ 
containing 0.25M sucrose and 1.5mM MgS04 pH 7.4, and centrifuged at 13,500 
rpm for 10 min at 4°C. The bottom of the gradient, containing the food vacuoles, 
was collected, suspended in 300J.i1 uptake buffer to which was added 1.2ml of the 
PercolFM solution and again centrifuged. The purified food vacuoles were collected, 
resuspended in 1ml uptake buffer and microfuged at 13,500g for 2 min to wash off 
the PercolFM• 
7.5. Preparation or erythrocyte ghosts ' 
Erythrocyte ghosts were prepared as described by Heidrich and Leutner (1974). The 
cells of 100 ml freshly drawn human blood were centrifuged at 120g for 10 min and 
then washed 3 times with a 5mM phosphate buffer, pH 8.0, containing O.15M NaCl. 
The cells were hemolysed w th 1,200 ml 5mM phosphate buffer, pH 8.0, by stirring 
at O°C for 20 min. The resulting ghosts were then washed 5-6 times at 4°C with the 
same buffer by centrifugation at 20,000g for 10 min until they were white. 
Erythrocyte ghosts were stored at -80°C in 5mM sodium phosphate, pH 8.0. 
7.6. Acetylcholine esterase activity 
The acetylcholine esterase (AchE) activity was determined by a modification of the 
method of Ellman et al. (1961). Enzyme assays were carried out with 200 J.il of 
freshly prepared O.lM sodium phosphate pH 7.5, 0.5mM 2,2' -dinitro-5,5'­
112 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 7: Methods 
dithiobenzoic acid, 0.6mM S-acetylthiocholine iodide to which was added 50).1.1 of a 
suspension of erythrocyte ghost. trophozoites or parasite plasma membrane, in 
, 
microtitre 96-well plates. lO).I.g of erythrocyte ghost protein, 3-5).1.g of trophozoite 
protein or 20llg of parasite plasma membrane protein were used to measure an initial 
rate. 50111 of P.B.S. or vesicle buffer was added to the control wells. Wells 
containing 200).1.1 H20 and 50111 of erythrocyte ghostsltrophozoiteslvesicles 
suspensions were including to subtract any absorbance due to the cells. Changes in 
absorbance at 405nm were measured for at least 20 min. using a 7520 Microplate 
Reader Cambridge Technology, Inc. 
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Figure 23: standard curve for the formation of5-thio-2-nitro-benzoic acid by 
measurement of the absorbance at A =405nm from 3 separate experiments (~ 
=0.9963). 
A standard curve for the formation of 5-thio-2-nitro-benzoic acid was set up by 
preparing dilutions of S-acetylthiocholine iodide ranging from 122 to 20nmol in 
O.lM sodium phosphate, 0.5mM 2,2'-dinitro-5,5'-dithiobenzoic acid. pH 7.5, in a 
final volume of 200).1.1 per well. lOllg of erythrocyte ghost protein was added to each 
well to initiate the reaction. After 20 min, absorbance values at 405nm were 
obtained as described above. 
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7.7. Parasite lactate dehydrogenase activity 
Measurements of parasite lactate dehydrogenase (pLDH) activity were carried out 
essentially as described by Makler and Hinrichs (1993a). For these measurements, 
5J..l.g oftrophozoites protein or membrane vesicle protein suspended in 20J..l.I P.B.S. or 
vesicle buffer was added to 100J..l.I Malstat™ reagent (Flow, inc.) and 25J..l.I 0.24 mM 
phenazine ethosulfate (PES)/1.96mM nitro blue tetrazolium (NBT) in microtitre 96­
well plates. 20J..tl of H20 was added to the control wells. Wells containing 20J..l.I 
trophozoitesl membrane vesicles and 125J..l.I H20 were included to subtract any 
absorbance due to the cells. Changes in absorbance at 620nm were measured for at 
least 20 min, using a 7520 Microplate Reader Cambridge Technology, Inc. 
A standard curve for the formation of reduced 3-acetylpyridine adenine dinucleotide 
(AP ADH) was set up by preparing serial dilutions of a solution containing 0.5mM­
7.8~ APADH (Sigma) and 0.18M L(+) lactic acid (sigma, 54.5mM Tris-HCI, 
0.2% triton X-IOO, pH 9.0. Final volume of this solution in each well was 100J..l.I, to 
which was added 25J..l.I of 24mM phenazine ethosulfate (PES)/1.96mM nitro blue 
tetrazolium (NBT) and 20 J..l.IH20. Absorbance values at 620nm were obtained as 
described above. 
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Figure 24: Standard curve for the formation of reduced 3-acetylpyridine adenine 
dinucleotide (AP ADH) by measurement of the absorbance at A. =620nm from 3 
separate experiments (C =0.994). 
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7.S. In vitro Plasmodium falciparum cytotoxicity assay 
The parasite lactate dehydrogenase (pLDH) assay was used for the evaluation of 
parasite viability in the presence of drug according to the method developed by 
Makler et al. (1993b). This assay is based on the fact that pLDH activity is 
distinguishable from host lactate dehydrogenase activity using the 3-acetylpyridine 
adenine dinucleotide (APAD) analogue ofnicotinamide adenine dinucleotide. 
Chloroquine diphosphate (2J.1M) was serially diluted two-fold in culture medium, in 
microtitre 96-well plates. The suspensions were dispensed in quadruplicate at lOOll1 
I well. To the control and blank: well, lOOll1 of culture medium was added. 
Sensitivity assay were initiated by adjusting the initial parasitemia to 2% with 0­
positive red blood cells (2% haematocrit) suspended in culture medium. lOOll1 of 
parasitised red blood cells was added to each well except the blank: wells. To the 
blank: wells, 200111 of unparasitised red blood cells (1% haematocrit) was added. 
Therefore, the ;final volume of each well was 200).ll and the haematocrit of both the 
parasitised red blood cells and the unparasitised erythrocytes was 1%. The plates 
were incubated at 37°C for 48 hours in 93% nitrogen, 4% carbon dioxide, 3% 
oxygen. 
At the end of the incubation period, the cultures were carefully resuspended and 
10111 from each well of resuspended culture was transferred into another microtitre 
96-wells plate that contained lOO1l1 of Malstat™ reagent and 25III of 0.24mM 
PES/L96mM NBT solution. The reduction of the tetrazolium to the blue formazan 
salt is an indication of parasite survival. Absorbance values were measured at 
620nm using a 7520 Microplate Reader Cambridge Technology, Inc. 
Percentage parasite survival was calculated using the following formula: 
Mean ofcontrol wells 
Percentage parasite survival X 100 
Mean ofdrug containing wells 
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7.9. Chloroquine accumulation in parasitised erythrocytes 
Parasitised erythrocytes, synchronised in the trophozoite stage, with a parasitemia 
between 3-5% and the haematocrit set at 1 % in culture medium were exposed to 
eH]-chloroquine (11.9Cilmmol, Amersham) in 1.5ml eppendorf vials. The control 
consisted of uninfected erythrocytes suspended at a final haematocrit of 1 % in 
culture medium. Unlabelled chloroquine was included for concentrations greater or 
equal to 100nM. The vials were incubated at 37°C for 1 hour. The incubations were 
terminated by centrifuging at 13,000 rpm for 2 min in a microfuge and the PRBC 
were washed twice with ice-cold medium. The eppendorf tip containing the PRBC 
was cut off and placed in a scintillation vial containing 4 ml of liquid scintillation 
cocktail and 1 ml 3.5% (MN) sodium hypochlorite, to bleach the red colour of the 
haemoglobin. Samples were shaken overnight and the radioactivity was counted in a 
Packard Tri-Carb 4640 liquid scintillation spectrophotometer. 
7.10. Chloroquine accumulation in parasite plasma membranes vesicles 
Membrane preparations were thawed rapidly at 37°C and 40llg of membrane vesicle 
protein were diluted in vesicle buffer (0.25M sucrose, lOmM Tris-HCI pH 7.4) 
containing 2mM MgCh. Chloroquine accumulation experiments were carried out in 
the presence or absence of 2mM ATP. All reactions were carried out in a final 
volume of Iml. To initiate chloroquine accumulation, eH]-chloroquine 
(11.9Cilmmol, Amersham) was added. Unlabelled chloroquine was included for 
concentrations greater or equal to 100nM. When additional drugs were used, they 
were preincubated for 15 min prior to the addition of [3H]-chloroquine. Incubations 
were carried out at 37°C for the specified length of time. The incubations were 
terminated by centrifugation at 13,000 rpm for 2 min in a microfuge. The 
membranes were then washed twice with ice-cold vesicle buffer. The eppendorf tip 
containing the membranes was cut off and placed in a scintillation vial containing 5 
ml of liquid scintillation cocktail. Samples were shaken overnight and the 
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radioactivity was counted in a Packard Tri-Carb 4640 liquid scintillation 
spectrophotometer. 
7.11. ATPase activity 
The ATPase activity was determined using a colorimetric assay adapted from those 
of Chifllet et al. (1988) and Doige et al. (1992). Enzyme assays were carried out 
with 50Jlg of freshly isolated Plasmodium jalciparom plasma membranes suspended 
in 450JlI of reaction buffer ( 50mM Tris-HCI, 0.15M ~CI, 2mM MgCh, 0.02% 
NaN3, pH 7.4). To initiate the reaction 50JJ.l of ATP in reaction buffer was added, 
giving a final concentration of 2mM ATP. A control containing 50Jlg of parasite 
plasma membranes suspended in 500JJ.l of reaction buffer was included to subtract 
any absorbance due to the membranes. Another control consisting of 500JJ.l reaction 
buffer containing 2mM ATP was added to evaluate the ATP hydrolysis. When drugs 
were used, they were preincubated for 15 minutes at room temperature prior to the 
addition of ATP and the appropriate controls were included. After 45 min. at 37°C, 
the suspensions were centrifuged at 13,000 rpm for 3 minutes to pellet the 
membranes. Aliquots of 100JlI of the resulting supernatant were transferred to the 
wells of a 96-well microtitre plate. The reaction was stopped by the addition of 
100Jll offresly prepared solution A (6% SDS, 3% L-ascorbic acid, 0.5% ammonium 
molybdate in 0.25M sulfuric acid). After 15 minutes, the phophoammoniumolybdate 
complex formed was stabilised by the addition of 100JlI of solution B (2% sodium 
citrate, 2% sodium arsenite, 2% acetic acid). After 15 minutes, the absorbance at 
710nm was measured using a 7520 Microplate Reader Cambridge Technology, Inc. 
A calibration curve for the inorganic phosphate determination was set up by 
preparing dilutions of sodium hydrogen phosphate ranging from 2 to 20nmol in 
reaction buffer in a final volume of 100Jll. These dilutions were assayed as 
described above. 
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Figure 25: Standard curve for the inorganic phosphate by measurement of the 
absorbance at f..,==- 710nm from 3 separate experiments with errors bars representing 
the standard deviation (r=0.999). 
7.12. Preparation of antibodies to Pghl 
7.12.1. Preparation of competent cells 
L-Broth medium was prepared by dissolving 5g Tryptone, 2.5g Yeast extract, 5g 
NaCI in 500ml distilled water. After sterilization by autodaving, ampicillin was 
added to a final conce tration of O.lmglml. 500ml of L-Broth medium was 
inoculated with 3 ml of an overnight culture of E. coli and incubated at 37°C with 
shaking until the absorbance at 650nm of the culture reached 0.2-0.3. The cells were 
then centrifuged at 5,000 rpm in a JA-1O Beckman rotor for 10 min at 4°C and 
resuspended in 40ml of ice-cold 60mM CaCh, 10mM Pipes, pH 7.2 by gentle 
pipetting action. After 20 min incubation on ice, the suspension was centrifuged at 
5,000 rpm in a JA-20 Beckman rotor for 5 min. The cells were resuspended in 4ml 
of 60mM CaCh, 10mM Pipes, pH 7.2, 15% glyceroL The resulting competent cells 
were frozen in liquid nitrogen and stored at -70°C. 
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7.12.2. Transformation ofEscherichia coli 
Two plasmid expression vectors pGex-3X constructs (Cowman et aI., 1991) 
encoding for the N-terminal ATP-binding site and the C-terminus portion of Pghl 
corresponding respectively to the amino acids residues 510-614 and 1252-1419 of 
Pghl (Foote et al., 1989) as a Pghl fusion protein with glutathione-S-transferase 
(GST) were generously provided by Dr A. Cowman, Walter and Elisa Hall Institute 
of Medical Research in Melbourne, Australia. These plasmids were transfonned 
either into E. coli strain JM-109 or XL-Blue. 1OJ!1 of plasmid DNA was incubated 
with 100 J!l of competent cells for Ih30 on ice. This solution was transferred to a 
42°C waterbath and heated for 2 min. 1 ml of prewanned (37°C) L-Broth agar (5g 
tryptone, 2.5g yeast extract, 5g NaCI, 7.5g bacto-agar, dissolved in 500ml H20 to 
which ampicillin was added after sterilization by autoclaving to a final concentration 
of O.lmg/ml) was added and the cells were incubated at 37°C for 1 hour. Aliquots of 
this solution were spread on L-Broth agar plates containing O.lmg/ml ampicilline 
and incubated overnight at 37°C. 
7.12.3. Plasmid DNA purification 
The DNA was purified using a small-scale plasmid DNA preparation system. 5 ml 
of an overnight culture of E.coli transfonned with the recombinant pGex-3X was 
centrifu~ed for 10 min at 2,000 rpm and resuspended in 200f.11 of 25mM Tris-HCI, 
pH 8.0, 10mM EDTA, 50mM glucose. After 5-min incubation, 2f.11 of RNase I 
(1 Omg/ml; Boehringer Mannheim) was added. The membranes were lysed with 
400f.11 of 5M NaOH, 10010 SDS and incubated for 5 min on ice. The genomic DNA 
was precipitated with 300f.11 of 3M potassium acetate and incubated for 5 to 10 min 
on ice. After a 5-min centrifugation in a microfuge at 4°C, the supernatant 
containing the plasmid DNA was transferred into an eppendorf. The plasmid DNA 
was precipitated with 600f.11 isopropanol and incubated for 30 min at -20°C. The 
DNA was microfuged for 5 min at room temperature and washed twice with 70% 
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ethanol at room temperature. The resulting purified DNA was resuspended in SOJ..lI 
TE-buffer (lmM EDTA, lOmM Tris-HCI, pH S.O). 
7.12.4. Enzymatic digestion of the plasmids 
Enzymatic digestions were carried out with 10J..lI of plasmid DNA, 2J..lI of buffer H 
(SuRE/Cut buffer H, Boehringer Mannheim), 1 J..lI of the specified restriction enzyme 
and 7J..lI of water. After 2 hours incubation at 37°C, the reaction was stopped by 
addition of 2J..lI of stop buffer (lOmM EDTA, pH 7.5, 0.25% Bromophenol blue, 
0.25% Xylene Cyanole and 30% Glycerol). Ten J..lI of the resulting digested DNA, 
the corresponding uncut plasmid and the A-phage DNA marker (New England 
BioLab) were loaded onto an 1% agarose gel. Gels were electrophoresed at 40mA 
for 50 minutes and revealed with 1 % ethidium bromide. 
7.12.5. Sequencing of the pfmdrl gene fragments 
Sequencing of the plasmid was performed by the method of Sanger (1977) using a 
Thermo Sequenase™ DNA polymerase (Amersham Pharmacia) and the CysTM 
Thermo Sequenase Dye Terminator Kit (Amersham Pharmacia Biotech.) The 
plasmids were amplified on a Gene Amp PCR System 9700 (perkin Elmer, Applied 
Biosystems). The sequencing primers consisted of a pGEX-3X forward primer: (23 
mer) 4pmollJ..ll: 5'-GGG CTG GeA AGe CAC GTT TGG TG 3' and a reverse 
primer: (23 mer) 4pmollJ..ll: 5'CGG GGA GeT GeA TGT GTC AGA GG-3'. The 
sequencing was carried out on an ALFexpress DNA Automated Sequencer 
(Amersham Pharmacia Biotech) according to the manufacturer's instructions. The 
electrophoresis was performed onto a 5% acrylamide gel for 13 hours at 55°C, using 
a standard gel cassette and 0.5mm spacers. Data were analysed by the ALFwin 
version 1.1 software (Amersham Pharmacia Biotech.). 
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7.12.6. ~xpression of the Pghl-GST fusion protein 
The expression of fusion proteins was perfonned basically as described by Smith 
and Johnson (1988). Overnight cultures of E.coli transfonned with the plasmid of 
interest were diluted 1: 10 in 900ml of L-Broth medium containing 0.1gil 
ampicilline. After 1 hour of growth at 37°C, bacteria were induced with O.lmM 
IPTG (isopropyl-~-D-thiogalactopyranoside, Promega). After a further 3-7 hours of 
growth, bacteria were pelleted by centrifugation for 10 min, at 5,000g in a GSA 
rotor (Beckman). At this point, bacteria pellets were frozen at -70°C before thawing 
and continuation of the protocol. 
7.12.7. Purification of the Pghl-GST fusion protein 
The induced cell pellet was resuspended in lOml ice-cold PBS containing ImM 
phenylmethylsulfonylfluoride (PMSF, Boehringer Mannheim) and 20J.1Wml 
Soybean Trypsin inhibitor (Sigma) and transferred to 14ml polypropylene tubes on 
ice. Cells were sonicated 4 times on ice for 20 seconds using an ultrasonic processor 
(Heat Systems lTItrasonic Inc., Model W-385) and Triton X-100 was added to a final 
concentration of 1%. After 15 min incubation on ice, the insoluble debris were 
pelleted by centrifugation at 10,000 rpm at 4°C for 5 min in a SS-34 rotor 
(Beckman). The supernatant was mixed with 2 ml of washed and swollen 
glutathione-agarose beads (Sigma) on a rotating platfonn at room temperature. After 
20-min incubation, the beads were washed 5 times with ice-cold P.B.S. by repeated 
centrifugation. Fusion protein was eluted by competition with free glutathione using 
2 X 2 min washes with 1 bead volume of 50 M Tris-HCI , pH 8.0 containing 5mM 
reduced glutathione (Sigma). The purified fusion proteins were freeze-dried and 
stored at -20°C. 
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7.12.8. immuDizatioD of rabbits 
The fusion proteins were redissolved in water to a concentration of 1.2mglml and 
either 1ml of Freund's complete adjuvant (CFA, Sigma) or incomplete Freund's 
adjuvant was added to 200JlI of the fusion protein suspension. New Zealand White 
rabbits were immunised by injection of 0.2mg of fusion protein together with 
Freund's complete adjuvant for the priming immunisation and incomplete Freund's 
adjuvant for the subsequent immunisations. Second and third immunisations were 
performed 30 days and 60 days respectively after the priming immunisation. 14 days 
after the last immunisation, 25ml of blood from each rabbit were harvested and 
incubated at 37°C for 1 hour. The red blood cells were removed by centrifugation 
and the resulting sera was stored at -70°C. 2 test bleeds of 5 ml each were performed 
respectively 10 days after the second immunisation and 7 days after the third 
immunization. As a control, 5ml of blood was taken before immunization of the 
rabbits and treated as described previously. 
7.12.9. Preparation of antibodies to aN-terminal Pghl peptide 
A peptide corresponding to the amino-acid 2-18 of Pgh 1 to which was added a 
cysteine residue (GKEQKEKKDGNLSIKEEYC) was synthesised at the 
Eidgen lssische Technishe Hochschule (ETH) Z1rich, Switzerland. To activate the 
carrier protein, 200JlI of a maleimidobenzyl-N-hydroxysuccinimide ester (MBS) 
solution (3.3mg of MBS in 330JlI dimethylformamide) was added to 12mg of pure 
ovalbumine (Sigma) in 600Jll PBS. After a 2 hours incubation, the unbound 
maleimide was removed by dialysis against PBS at 4°C. The coupling of 2mg of 
peptide dissolved in 20JlI water to 2mg ovalbumin-benzoyl-maleimide in 100mM 
phosphate buffer pH 7.5 was carried out at 4°C for 20 hours. Aliquots of 200!!g of 
the conjugate were stored at -70°C. These aliquots ofconjugate were then injected to 
the rabbits as described in section 7.12.8. 
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7.12.10. Dot blots 
Ovalbumin (0. 14/-lg), activated ovalbumin (0. 17/-lg) and a peptide (3/-lg) 
corresponding to the N-terminal 18 amino acids of Pghl were dissolved in P.B.S 
and pipetted onto nitrocellulose membrane (micro Separation, Inc.). The dried 
membranes were blocked for 2 hours in 5% milkpowder, 0.1% Tween-20 in P.B.S. 
and expo$ed to the rabbit serum against Pghl 1-1 8 peptide diluted 1 :2000 with in 5% 
milkpowder, 0.1% Tween-20 in P.B.S. for 2 hours. A negative control consisting of 
the rabbit pre-immune serum diluted 1 :2000 was included. The membranes were 
rinced 3 times with 5% milkpowder, 0.1% Tween-20 in P.B.S. and exposed to a 
horseraddish peroxydase conjugated anti-rabbit (Sigma) at a 1: 4000 dilution for 1 
hour. The membranes were again rinced with 5% milkpowder, 0.1% Tween-20 in 
P.B.S. for 15 minutes, followed by 3 washes with PBS/O.l% Tween-20 and finally 
rinced with PBS. Visualisation was performed with the Pierce SuperSignal CL-HRP 
chemiluminescent substrate. 
7.13. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out essentially as described by Laemmli (1970). SDS-PAGE was performed 
on a 10% acrylamide slab gel (3mm thickness) and a 5% stacking geL Samples and 
molecular weight standards (Biolabs, Prestained, protein marker broad range) were 
dissolved in Y2 volume of 3X reducing SDS-sample buffer (Biolabs, 187.5mM Tris­
HCI, pH 6.8, 6% (w/v) SDS, 30% glycerol, 0.03% phenol red, 0.125M 
dithiothreitol). The sample and standards were heated to 95-100°C for 5 min before 
loading onto the gel. Gels were electrophoresed at 100 m V until the dye reached the 
bottom of the gel in a mini-gel apparatus (Bio-Rad). Gels were either silver-stained 
or processed for western blot analysis. 
123 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 7: Methods 
7.14. Silver staining of gel 
SDS-PAGE gels were silver-stained as described by Wray et al. (1981). Gels slabs 
were soaked in 50% methanol, 0.7% formaldehyde for at least 1 hour. They were 
then rinsed twice with H20 and stained for 15 min in a freshly prepared 0.8 % silver 
nitrate solution. This solution was prepared by adding the solution A (0.8g AgN03 
in 4ml H20) to the solution B (21ml 0.36% NaOH, L4ml 25% ammonia) while 
shaking and by increasing the volume to 100ml. Gels were again rinced in H20 and 
developed in 0.02% formaldehyde, 0.005% citric acid until the desired contrast was 
obtained. The development was stopped by placing the gel in 50% methanol, 10% 
acetic acid for 15 min. 
7.15. Western blotting 
Samples were electrophoretically transferred to 0.45!lm pure nitrocellulose 
membrane (Bio-Rad) using the Bio-Rad Mini Trans Blot system in a transfer buffer 
consisting of 0.025M Tris-HCI, pH 8.3, 0.192M glycine, 0.1% SDS and 20% 
methanol at 100mV for 1 hour. Nitrocellulose blots were blocked for at least 3 hours 
using 10% milk powder in P.B.S./Tween 20 (0.1%), rinced with P.B.S.lTween 20 
(0.1 %), and exposed to the appropriate antibody for 1 hour. Affinity-purified 
antibodies to Pgh 1 were used at a dilution of 1 : 1000 while antibodies against human 
immunoglobulins (Sigma) were used at a 1 :5000 dilution. The nitrocellulose was 
rinced with P.B.S./Tween 20 (0.1%) and exposed to an alkaline phosphatase­
conjugated anti-rabbit IgG (Sigma) at a 1: 10000 dilution, for 30 min. The 
nitrocellulose was again rinced with P.B.S.lTween 20 (0.1%) and then with a wash 
solution (100mM NaCI, 100mM Tris-HCI, 5mM MgClz, pH 9.5). Bound antibodies 
were detected colorimetrically using the bromochloroindolyl phosphate/nitro-blue 
tetrazolium (Sigma) substrate system. 
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In some experiments, bound antibodies were detected by autoradiography with 
peroxydase-Iabeled anti-rabbit antibodies and the Boehringer Mannhein detection 
chemiluminescence detection kit. 
7.16. Electron microscopy of parasite plasma membranes vesicles, trophozoites 
and parasitised erythrocytes 
Samples were fixed with glutaraldehyde (0.8%)/formaldehyde (8%) in PBS for 1 
hour at room temperature and washed in PBS, followed by addition of 50mM N}4CI 
for 30 minutes and 2 washes in PBS. Samples were dehydrated in 70% ethanol and 
embedded in LR White resin (polyscience Inc.) which was then polymerised at 60°C 
for 28 hours. Then Iflm-thick sections were cut using a reichert Ultracut S 
ultramicrotome. Sections were mounted on copper grids and stained with 2% uranyl 
acetate and lead acetate. Samples were viewed on a JEM 200CX transmission 
electron microscope. 
7.17. Immunoelectron microscopy 
Sections mounted on copper grids prepared as described previously (section 7.15) 
were incubated in PBSIBSA (0.1 %) for 30 minutes, and then with rabbit anti-Pghb_ 
18 antibodies diluted 1:50 in PBSIBSA (0.1%) for 2 hours at room temperature. After 
washing in PBSIBSA (0.1%), thin-sections were exposed to a goat anti-rabbit 
antibody labelled with 200m-gold particles for 1 hour at room temperature. Sections 
were then washed in PBSIBSA (0.1%) and stained with 2% uranyl acetate. Samples 
were viewed on a JEM 200CX transmission electron microscope. 
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7.1S. Protein determination 
Protein determinations were performed by the method ofLowry et al. (1951) using a 
protocol developed by Peterson (1977). Samples were brought to a final volume of 
1.0ml with water and Iml of 2.5% sodium carbonate/0.025% copper sulfate/0.05% 
potassium tartrate/2.5% SDS/0.2M sodium hydroxyde was added. After 10 minutes 
at room temperature, 0.5ml of a 1:5 solution of Folin-Ciocalteu phenol reagent 
(Merck) was added. Samples were mixed immediately and aliquots of 200lli were 
transferred into the wells of a 96-well microtitre plate. After 30 minutes, absorbance 
values at 7lOnm were measured using a 7520 Microplate Reader Cambridge 
Technology, Inc. 
Increased concentrations of Bovine serum albumin was used to set up standard 
curves. 
7.19. Data analysis 
Statistical significance (p-values) was established using the two-tailed Student's t­
test using the computer program GrapbPad Prism® (GrapbPad software). The level 
of significance was set at pS;0.05. Data for dose-response curves were fitted using 
GrapbPad Prism® (GrapbPad software) and the concentration of chloroquine that 
inhibits 50% of parasite growth (ICso) was determined from the curve using this 
program. 
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Annexe 

Preparation of antibodies to aN-terminal Pghl peptide 

Antibodie$ against Pghl peptide were prepared in our laboratory (M. Lindt). A 
peptide corresponding to the N-terminal 18 amino acids of pghl was synthesised 
and a cysteine residue was added at the C-terminus to permit coupling to a carrier 
protein via a maleimide function. Since the pgh 1 peptide represents the N-terminus 
of the protein, the peptide was conjugated to a carrier via the C-terminus so that the 
N-terminus of the peptide was visible to the immune system. Antibodies directed 
against this peptide-conjugate should recognise the N-terminus of the pghl protein. 
The conjugation reagent used was maleimidobenzoyl-N-hydroxysuccinimide ester 
(MBS). This reagent reacts with amino groups ,on protein via the N­
hydroxysuccinimide ester to yield protein-benzoyl-maleimide. The peptide was then 
conjugated by simply co-incubating the thiolated peptide with the protein-benzoyl­
maleimide and injected to the rabbits as described in methods section 7.12.9. Dot 
blot experiments showed that the peptide as well as the carrier protein was 
recognised by the immune sera. Western blot experiments showed that the 
trophozoites contain a protein that is recognised by the anti-conjugate serum. The 
molecular weight of the protein is approximately 75kDa. Surprisingly, several bands 
were recognised in the sample of type B+ blood, the dominant band being at 55kDa. 
Since the rabbit was immunised with an ovalbumin-peptide conjugate the cross­
reactivity with human blood might arise out of homology between ovalbumin and 
serum proteins. ). 
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Recognition of the N-terminal 18 amino acid peptide of Pghl by rabbit serum 
against Pghlt-18 peptide 
To examme whether the serum recogruses the peptide, dot experiments were 
performed. Ovalbumin (0. 14!lg), activated ovalbumin (0. 17!lg) and Pgh11_18 peptide 
(3 !lg) were pipetted onto nitrocellulose membranes and incubated with rabbit serum 
against Pghl 1_18 peptide. A negative control consisting of the pre-immune rabbit 
serum was included. Visualisation was performed with goat anti-rabbit antibodies 
conjugated to horseradish peroxidase using a chemiluminescent system. The 
immune serum recognised the carrier protein and the peptide whereas the negative 
serum did not recognised any of the antigens (Plate 19). 
Ovalbumin 
Activated 
ovalbumin 
1 2 
Plate 19: Dot blot profiles of ovalbumin (0. 14!lg), activated ovalbumin (0. 17!lg) and 
Pgh 11-18 peptide (3 !lg) revealed with rabbit serum against Pgh 11-18 peptide (lane 1) 
and pre-immune rabbit serum (lane 2). Recognised bands were detected using 
chemiluminescence. 
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Recognition ofPghl in trophozoites by rabbit serum against Pghll-18 peptide 
Western blot of trophozoites revealed with rabbit serum against Pghh18 peptide 
were perfonned to determine whether these antibodies recognised Pgh 1. Equal 
amount (20llg) of purified DlO trophozoite protein and full blood protein (serum 
and erythrocytes) of type B+ were electrophoresed onto a 12.5% SDS-PAGE gel, 
transferred to nitrocellulose and probed with rabbit serum against Pgh 11-18 peptide. 
Visualisation was perfonned with goat-anti-rabbit antibodies conjugated to alkaline 
phosphatase. 
Western blot experiments showed that the D 1 0 trophozoites contain a protein of 
approximate molecular weight of 75 Kda that is recognised by the anti-conjugate 
serum. Several bands are recognised in the lane containing the type B+ blood, the 
dominant band corresponding to a molecular weight of 55 Kda (plate 20). 
1 2 3 
175 
83 
62 
47 
32 
Plate 20: Equal amount (20llg) of purified D 1 0 trophozoite protein (lane 1) and full 
blood protein (serum and erythrocytes) of type B+ (lane 2) were electrophoresed, 
transferred to nitrocellulose and probed with rabbit serum against PghII-18 peptide. 
Recognised band were detected colorimetrically with goat-anti-rabbit antibodies 
conjugated to alkaline phosphatase. Lane 3 contains protein markers with 
approximate molecular weights expressed in kDa. 
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